ID	Gene Name	Species	BIOCARTA	COG_ONTOLOGY	GOTERM_BP_DIRECT	GOTERM_CC_DIRECT	GOTERM_MF_DIRECT	INTERPRO	KEGG_PATHWAY	OMIM_DISEASE	PIR_SUPERFAMILY	SMART	UP_KW_BIOLOGICAL_PROCESS	UP_KW_CELLULAR_COMPONENT	UP_KW_DISEASE	UP_KW_DOMAIN	UP_KW_LIGAND	UP_KW_MOLECULAR_FUNCTION	UP_KW_PTM	UP_SEQ_FEATURE
P41932	14-3-3 domain-containing protein;14-3-3-like protein 1(par-5)	Caenorhabditis elegans			GO:0000132~establishment of mitotic spindle orientation,GO:0001708~cell fate specification,GO:0006611~protein export from nucleus,GO:0007165~signal transduction,GO:0007346~regulation of mitotic cell cycle,GO:0008104~protein localization,GO:0008340~determination of adult lifespan,GO:0009792~embryo development ending in birth or egg hatching,GO:0009949~polarity specification of anterior/posterior axis,GO:0010070~zygote asymmetric cell division,GO:0010286~heat acclimation,GO:0010468~regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0022414~reproductive process,GO:0030590~first cell cycle pseudocleavage,GO:0035046~pronuclear migration,GO:0045167~asymmetric protein localization involved in cell fate determination,GO:0051220~cytoplasmic sequestering of protein,GO:0051321~meiotic cell cycle,GO:0051457~maintenance of protein location in nucleus,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005938~cell cortex,	GO:0005515~protein binding,	IPR000308:14-3-3,IPR023409:14-3-3_CS,IPR023410:14-3-3_domain,IPR036815:14-3-3_dom_sf,	cel04212:Longevity regulating pathway - worm,		PIRSF000868:14-3-3,	SM00101:14_3_3,		KW-0539~Nucleus,KW-0963~Cytoplasm,						DOMAIN:14-3-3,
A7S3J7	40S ribosomal protein S3a(LOC5513560)	Nematostella vectensis			GO:0006412~translation,	GO:0005829~cytosol,GO:0005840~ribosome,GO:0022627~cytosolic small ribosomal subunit,	GO:0003735~structural constituent of ribosome,	IPR001593:Ribosomal_eS1,IPR018281:Ribosomal_eS1_CS,IPR027500:Ribosomal_eS1_euk,	nve03010:Ribosome,			SM01397:Ribosomal_S3Ae,		KW-0963~Cytoplasm,				KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,		COMPBIAS:Basic and acidic residues,REGION:Disordered,
B2RX12	ATP-binding cassette, sub-family C member 3(Abcc3)	Mus musculus	m_mrpPathway:Multi-Drug Resistance Factors,m_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,		GO:0006855~xenobiotic transmembrane transport,GO:0015721~bile acid and bile salt transport,GO:0015722~canalicular bile acid transport,GO:0015779~glucuronoside transport,GO:0042908~xenobiotic transport,GO:0055085~transmembrane transport,GO:0071716~leukotriene transport,GO:0098656~monoatomic anion transmembrane transport,	GO:0005886~plasma membrane,GO:0009925~basal plasma membrane,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,	GO:0005524~ATP binding,GO:0008559~ABC-type xenobiotic transporter activity,GO:0015164~glucuronoside transmembrane transporter activity,GO:0015431~ABC-type glutathione S-conjugate transporter activity,GO:0015432~ABC-type bile acid transporter activity,GO:0016887~ATP hydrolysis activity,GO:0042626~ATPase-coupled transmembrane transporter activity,GO:0042910~xenobiotic transmembrane transporter activity,GO:0071714~icosanoid transmembrane transporter activity,	IPR003439:ABC_transporter-like_ATP-bd,IPR003593:AAA+_ATPase,IPR005292:MRP,IPR011527:ABC1_TM_dom,IPR017871:ABC_transporter-like_CS,IPR027417:P-loop_NTPase,IPR036640:ABC1_TM_sf,IPR050173:ABC_transporter_C,	mmu01523:Antifolate resistance,mmu02010:ABC transporters,mmu04976:Bile secretion,mmu04981:Folate transport and metabolism,			SM00382:AAA,	KW-0445~Lipid transport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,		KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-1278~Translocase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:ABC transmembrane type-1,DOMAIN:ABC transmembrane type-1 1,DOMAIN:ABC transmembrane type-1 2,DOMAIN:ABC transporter,DOMAIN:ABC transporter 1,DOMAIN:ABC transporter 2,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=10,TRANSMEM:Helical; Name=11,TRANSMEM:Helical; Name=12,TRANSMEM:Helical; Name=13,TRANSMEM:Helical; Name=14,TRANSMEM:Helical; Name=15,TRANSMEM:Helical; Name=16,TRANSMEM:Helical; Name=17,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,TRANSMEM:Helical; Name=8,TRANSMEM:Helical; Name=9,
E9Q236	ATP-binding cassette, sub-family C member 4(Abcc4)	Mus musculus		Defense mechanisms,	GO:0006855~xenobiotic transmembrane transport,GO:0015721~bile acid and bile salt transport,GO:0015732~prostaglandin transport,GO:0015747~urate transport,GO:0015850~organic hydroxy compound transport,GO:0032310~prostaglandin secretion,GO:0034775~glutathione transmembrane transport,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0055085~transmembrane transport,GO:0060271~cilium assembly,GO:0070730~cAMP transport,GO:0071716~leukotriene transport,GO:0140115~export across plasma membrane,GO:1901571~fatty acid derivative transport,GO:1903790~guanine nucleotide transmembrane transport,	GO:0005730~nucleolus,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0031088~platelet dense granule membrane,GO:0098591~external side of apical plasma membrane,	GO:0001409~guanine nucleotide transmembrane transporter activity,GO:0005524~ATP binding,GO:0008559~ABC-type xenobiotic transporter activity,GO:0015132~prostaglandin transmembrane transporter activity,GO:0015143~urate transmembrane transporter activity,GO:0015216~purine nucleotide transmembrane transporter activity,GO:0015431~ABC-type glutathione S-conjugate transporter activity,GO:0015432~ABC-type bile acid transporter activity,GO:0015562~efflux transmembrane transporter activity,GO:0015665~alcohol transmembrane transporter activity,GO:0016887~ATP hydrolysis activity,GO:0034634~glutathione transmembrane transporter activity,GO:0042626~ATPase-coupled transmembrane transporter activity,GO:0042910~xenobiotic transmembrane transporter activity,GO:0140359~ABC-type transporter activity,	IPR003439:ABC_transporter-like_ATP-bd,IPR003593:AAA+_ATPase,IPR011527:ABC1_TM_dom,IPR017871:ABC_transporter-like_CS,IPR027417:P-loop_NTPase,IPR030240:ABCC4_TMD1,IPR036640:ABC1_TM_sf,IPR047083:ABCC4_TMD2,IPR050173:ABC_transporter_C,	mmu01523:Antifolate resistance,mmu02010:ABC transporters,mmu04024:cAMP signaling pathway,mmu04976:Bile secretion,mmu04981:Folate transport and metabolism,			SM00382:AAA,	KW-0445~Lipid transport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,		KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-1278~Translocase,	KW-0597~Phosphoprotein,	DOMAIN:ABC transmembrane type-1,DOMAIN:ABC transmembrane type-1 1,DOMAIN:ABC transmembrane type-1 2,DOMAIN:ABC transporter,DOMAIN:ABC transporter 1,DOMAIN:ABC transporter 2,MOTIF:PDZ-binding,REGION:Disordered,TRANSMEM:Helical,
Q8CDM1	ATPase family, AAA domain containing 2(Atad2)	Mus musculus			GO:0006334~nucleosome assembly,GO:0006337~nucleosome disassembly,GO:0006338~chromatin remodeling,GO:0045815~transcription initiation-coupled chromatin remodeling,GO:0045893~positive regulation of DNA-templated transcription,GO:0045944~positive regulation of transcription by RNA polymerase II,GO:0140588~chromatin looping,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003682~chromatin binding,GO:0003689~DNA clamp loader activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATP hydrolysis activity,GO:0042393~histone binding,GO:0061775~cohesin loader activity,GO:0140584~chromatin extrusion motor activity,GO:0140665~ATP-dependent H3-H4 histone complex chaperone activity,GO:0140849~ATP-dependent H2AZ histone chaperone activity,	IPR001487:Bromodomain,IPR003593:AAA+_ATPase,IPR003959:ATPase_AAA_core,IPR003960:ATPase_AAA_CS,IPR027417:P-loop_NTPase,IPR036427:Bromodomain-like_sf,IPR041569:AAA_lid_3,IPR045199:ATAD2-like,				SM00297:BROMO,SM00382:AAA,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,		KW-0103~Bromodomain,KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0010~Activator,KW-0378~Hydrolase,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:Bromo,REGION:Disordered,
Q16720	ATPase plasma membrane Ca2+ transporting 3(ATP2B3)	Homo sapiens			GO:0034220~monoatomic ion transmembrane transport,GO:0051480~regulation of cytosolic calcium ion concentration,GO:0099509~regulation of presynaptic cytosolic calcium ion concentration,GO:1903779~regulation of cardiac conduction,GO:1990034~calcium ion export across plasma membrane,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0042734~presynaptic membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0098688~parallel fiber to Purkinje cell synapse,GO:0098978~glutamatergic synapse,GO:0098982~GABA-ergic synapse,GO:1903561~extracellular vesicle,GO:1990032~parallel fiber,	GO:0005388~P-type calcium transporter activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0015085~calcium ion transmembrane transporter activity,GO:0016887~ATP hydrolysis activity,GO:0030165~PDZ domain binding,GO:0046872~metal ion binding,GO:1905056~P-type calcium transporter activity involved in regulation of presynaptic cytosolic calcium ion concentration,	IPR001757:P_typ_ATPase,IPR004014:ATPase_P-typ_cation-transptr_N,IPR006068:ATPase_P-typ_cation-transptr_C,IPR006408:P-type_ATPase_IIB,IPR008250:ATPase_P-typ_transduc_dom_A_sf,IPR018303:ATPase_P-typ_P_site,IPR022141:ATP_Ca_trans_C,IPR023214:HAD_sf,IPR023298:ATPase_P-typ_TM_dom_sf,IPR023299:ATPase_P-typ_cyto_dom_N,IPR036412:HAD-like_sf,IPR044492:P_typ_ATPase_HD_dom,	hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04925:Aldosterone synthesis and secretion,hsa04961:Endocrine and other factor-regulated calcium reabsorption,hsa04970:Salivary secretion,hsa04972:Pancreatic secretion,hsa04978:Mineral absorption,	302500~Spinocerebellar ataxia, X-linked 1,		SM00831:Cation_ATPase_N,	KW-0109~Calcium transport,KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-0770~Synapse,KW-0966~Cell projection,KW-1003~Cell membrane,	KW-0225~Disease variant,KW-0523~Neurodegeneration,	KW-0175~Coiled coil,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0106~Calcium,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0112~Calmodulin-binding,KW-1278~Translocase,	KW-0597~Phosphoprotein,	ACT_SITE:4-aspartylphosphate intermediate,COMPBIAS:Basic and acidic residues,DOMAIN:Cation-transporting P-type ATPase N-terminal,DOMAIN:Plasma membrane calcium transporting P-type ATPase C-terminal,MUTAGEN:D->A: Impaired ATPase activity.,REGION:Calmodulin-binding subdomain A,REGION:Calmodulin-binding subdomain B,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q9I8E6	COPI coat complex subunit gamma 2(copg2)	Takifugu rubripes			GO:0006886~intracellular protein transport,GO:0006888~endoplasmic reticulum to Golgi vesicle-mediated transport,GO:0006891~intra-Golgi vesicle-mediated transport,GO:0009306~protein secretion,GO:0016192~vesicle-mediated transport,GO:0072384~organelle transport along microtubule,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0030126~COPI vesicle coat,	GO:0005198~structural molecule activity,	IPR002553:Clathrin/coatomer_adapt-like_N,IPR009028:Coatomer/calthrin_app_sub_C,IPR011989:ARM-like,IPR012295:TBP_dom_sf,IPR013040:Coatomer_gsu_app_Ig-like_dom,IPR013041:Clathrin_app_Ig-like_sf,IPR016024:ARM-type_fold,IPR017106:Coatomer_gsu,IPR032154:Coatomer_g_Cpla,IPR037067:Coatomer_gsu_app_sf,			PIRSF037093:Coatomer_gamma_subunit,		KW-0653~Protein transport,KW-0813~Transport,KW-0931~ER-Golgi transport,	KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0968~Cytoplasmic vesicle,		KW-0677~Repeat,				DOMAIN:Clathrin/coatomer adaptor adaptin-like N-terminal,DOMAIN:Coatomer gamma subunit appendage Ig-like subdomain,DOMAIN:Coatomer subunit gamma C-terminal,REGION:Disordered,REPEAT:HEAT 1,REPEAT:HEAT 2,REPEAT:HEAT 3,REPEAT:HEAT 4,REPEAT:HEAT 5,REPEAT:HEAT 6,
Q80TR8	DDB1 and CUL4 associated factor 1(Dcaf1)	Mus musculus			GO:0000122~negative regulation of transcription by RNA polymerase II,GO:0006338~chromatin remodeling,GO:0016567~protein ubiquitination,GO:0030183~B cell differentiation,GO:0033151~V(D)J recombination,GO:0035212~cell competition in a multicellular organism,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043687~post-translational protein modification,GO:0045732~positive regulation of protein catabolic process,	GO:0001650~fibrillar center,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0008180~COP9 signalosome,GO:0080008~Cul4-RING E3 ubiquitin ligase complex,	GO:0004676~3-phosphoinositide-dependent protein kinase activity,GO:0004677~DNA-dependent protein kinase activity,GO:0004679~AMP-activated protein kinase activity,GO:0004694~eukaryotic translation initiation factor 2alpha kinase activity,GO:0004711~ribosomal protein S6 kinase activity,GO:0005524~ATP binding,GO:0030331~nuclear estrogen receptor binding,GO:0035175~histone H3S10 kinase activity,GO:0035402~histone H3T11 kinase activity,GO:0035403~histone H3T6 kinase activity,GO:0035979~histone H2AXS139 kinase activity,GO:0044022~histone H3S28 kinase activity,GO:0044023~histone H4S1 kinase activity,GO:0044024~histone H2AS1 kinase activity,GO:0044025~histone H2BS14 kinase activity,GO:0072354~histone H3T3 kinase activity,GO:0072371~histone H2AS121 kinase activity,GO:0072518~Rho-dependent protein serine/threonine kinase activity,GO:0106310~protein serine kinase activity,GO:0140823~histone H2BS36 kinase activity,GO:0140855~histone H3S57 kinase activity,GO:0140857~histone H3T45 kinase activity,GO:1990244~histone H2AT120 kinase activity,GO:1990756~ubiquitin-like ligase-substrate adaptor activity,	IPR006594:LisH,IPR011989:ARM-like,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR016024:ARM-type_fold,IPR033270:VPRBP/DCAF1,IPR036322:WD40_repeat_dom_sf,	mmu05170:Human immunodeficiency virus 1 infection,			SM00667:LisH,	KW-0804~Transcription,KW-0805~Transcription regulation,KW-0833~Ubl conjugation pathway,KW-0945~Host-virus interaction,	KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0677~Repeat,KW-0853~WD repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0156~Chromatin regulator,KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Pro residues,DOMAIN:Chromo,DOMAIN:LisH,MOTIF:DWD box 1,MOTIF:DWD box 2,MUTAGEN:R->A: Loss of interaction with DDB1 and strong decrease in TET2 monoubiquitination; when associated with A-1246.,MUTAGEN:R->A: Loss of interaction with DDB1 and strong decrease in TET2 monoubiquitination; when associated with A-1282.,REGION:Disordered,REGION:Interaction with NF2,REGION:Protein kinase-like,REGION:WD repeat-like region,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,
P81999	DnaJ heat shock protein family (Hsp40) member B11(DNAJB11)	Canis lupus familiaris		Posttranslational modification, protein turnover, chaperones,	GO:0006457~protein folding,GO:0016556~mRNA modification,GO:0050768~negative regulation of neurogenesis,GO:0051604~protein maturation,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0101031~protein folding chaperone complex,	GO:0005102~signaling receptor binding,GO:0051082~unfolded protein binding,GO:0051787~misfolded protein binding,	IPR001623:DnaJ_domain,IPR002939:DnaJ_C,IPR008971:HSP40/DnaJ_pept-bd,IPR018253:DnaJ_domain_CS,IPR036869:J_dom_sf,IPR051736:DnaJ-B11-like,	cfa04141:Protein processing in endoplasmic reticulum,			SM00271:DnaJ,		KW-0256~Endoplasmic reticulum,		KW-0732~Signal,		KW-0143~Chaperone,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:J,
P81999	DnaJ heat shock protein family (Hsp40) member B11(DNAJB11)	Canis lupus dingo			GO:0006457~protein folding,GO:0016556~mRNA modification,GO:0050768~negative regulation of neurogenesis,GO:0051604~protein maturation,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0101031~protein folding chaperone complex,	GO:0005102~signaling receptor binding,GO:0051082~unfolded protein binding,GO:0051787~misfolded protein binding,	IPR001623:DnaJ_domain,IPR002939:DnaJ_C,IPR008971:HSP40/DnaJ_pept-bd,IPR018253:DnaJ_domain_CS,IPR036869:J_dom_sf,IPR051736:DnaJ-B11-like,	clud04141:Protein processing in endoplasmic reticulum,			SM00271:DnaJ,		KW-0256~Endoplasmic reticulum,		KW-0732~Signal,		KW-0143~Chaperone,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:J,
Q7RTR2	NLR family CARD domain containing 3(NLRC3)	Homo sapiens			GO:0007249~canonical NF-kappaB signal transduction,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032687~negative regulation of interferon-alpha production,GO:0032688~negative regulation of interferon-beta production,GO:0032715~negative regulation of interleukin-6 production,GO:0032720~negative regulation of tumor necrosis factor production,GO:0035556~intracellular signal transduction,GO:0042110~T cell activation,GO:0043124~negative regulation of canonical NF-kappaB signal transduction,GO:0045824~negative regulation of innate immune response,GO:0048147~negative regulation of fibroblast proliferation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0050728~negative regulation of inflammatory response,GO:0051898~negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,GO:1900016~negative regulation of cytokine production involved in inflammatory response,GO:1900226~negative regulation of NLRP3 inflammasome complex assembly,GO:1901223~negative regulation of non-canonical NF-kappaB signal transduction,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0034451~centriolar satellite,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0036312~phosphatidylinositol 3-kinase regulatory subunit binding,	IPR001611:Leu-rich_rpt,IPR007111:NACHT_NTPase,IPR027417:P-loop_NTPase,IPR032675:LRR_dom_sf,IPR041075:NOD1/2_WH,IPR041267:NLRP_HD2,IPR051261:NLR,IPR052201:LRR-containing_regulator,				SM00368:LRR_RI,		KW-0963~Cytoplasm,		KW-0433~Leucine-rich repeat,KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,			DOMAIN:NACHT,MOTIF:TRAF6-binding,MUTAGEN:SLQE->AAAA: Strong decrease of TRAF6-binding.,MUTAGEN:SVEE->AAAA: Almost no effect on TRAF6-binding.,REGION:Disordered,REPEAT:LRR 1,REPEAT:LRR 10,REPEAT:LRR 11,REPEAT:LRR 12,REPEAT:LRR 13,REPEAT:LRR 14,REPEAT:LRR 15,REPEAT:LRR 16,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,
B0FPE9	NLR family pyrin domain containing 3(NLRP3)	Macaca mulatta			GO:0002674~negative regulation of acute inflammatory response,GO:0002830~positive regulation of type 2 immune response,GO:0006954~inflammatory response,GO:0009595~detection of biotic stimulus,GO:0032731~positive regulation of interleukin-1 beta production,GO:0032753~positive regulation of interleukin-4 production,GO:0044546~NLRP3 inflammasome complex assembly,GO:0045087~innate immune response,GO:0045630~positive regulation of T-helper 2 cell differentiation,GO:0045944~positive regulation of transcription by RNA polymerase II,GO:0050729~positive regulation of inflammatory response,GO:0051260~protein homooligomerization,GO:1901223~negative regulation of non-canonical NF-kappaB signal transduction,GO:2000553~positive regulation of T-helper 2 cell cytokine production,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005815~microtubule organizing center,GO:0016020~membrane,GO:0031021~interphase microtubule organizing center,GO:0072559~NLRP3 inflammasome complex,	GO:0005524~ATP binding,GO:0016887~ATP hydrolysis activity,GO:0035591~signaling adaptor activity,GO:0043531~ADP binding,GO:0043565~sequence-specific DNA binding,GO:0070273~phosphatidylinositol-4-phosphate binding,GO:0140297~DNA-binding transcription factor binding,GO:0140299~molecular sensor activity,GO:1901981~phosphatidylinositol phosphate binding,	IPR001611:Leu-rich_rpt,IPR004020:DAPIN,IPR007111:NACHT_NTPase,IPR011029:DEATH-like_dom_sf,IPR027417:P-loop_NTPase,IPR029495:NACHT-assoc,IPR032675:LRR_dom_sf,IPR041075:NOD1/2_WH,IPR041267:NLRP_HD2,IPR050637:NLRP_innate_immun_reg,	mcc04217:Necroptosis,mcc04621:NOD-like receptor signaling pathway,mcc04623:Cytosolic DNA-sensing pathway,mcc04625:C-type lectin receptor signaling pathway,mcc05132:Salmonella infection,mcc05133:Pertussis,mcc05135:Yersinia infection,mcc05164:Influenza A,mcc05171:Coronavirus disease - COVID-19,mcc05417:Lipid and atherosclerosis,			SM00368:LRR_RI,SM01288:FISNA,SM01289:PYRIN,	KW-0391~Immunity,KW-0395~Inflammatory response,KW-0399~Innate immunity,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0206~Cytoskeleton,KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0964~Secreted,KW-1271~Inflammasome,	KW-1008~Amyloidosis,	KW-0433~Leucine-rich repeat,KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0010~Activator,KW-0378~Hydrolase,	KW-0449~Lipoprotein,KW-0564~Palmitate,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1015~Disulfide bond,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DISULFID:Redox-active,DOMAIN:FISNA,DOMAIN:NACHT,DOMAIN:Pyrin,LIPID:S-palmitoyl cysteine,MOTIF:KFERQ-like motif 1,MOTIF:KFERQ-like motif 2,MOTIF:KFERQ-like motif 3,MOTIF:KFERQ-like motif 4,REGION:Required for binding to phosphatidylinositol 4-phosphate (PtdIns4P),REPEAT:LRR 1,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,
P81436	O-linked N-acetylglucosamine (GlcNAc) transferase(OGT)	Oryctolagus cuniculus			GO:0006110~regulation of glycolytic process,GO:0006111~regulation of gluconeogenesis,GO:0006325~chromatin organization,GO:0006493~protein O-linked glycosylation,GO:0006915~apoptotic process,GO:0016485~protein processing,GO:0031397~negative regulation of protein ubiquitination,GO:0032922~circadian regulation of gene expression,GO:0045944~positive regulation of transcription by RNA polymerase II,GO:0071333~cellular response to glucose stimulus,GO:0160076~negative regulation of non-canonical inflammasome complex assembly,GO:1904263~positive regulation of TORC1 signaling,	GO:0000123~histone acetyltransferase complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0017122~protein N-acetylglucosaminyltransferase complex,	GO:0005515~protein binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0016262~protein N-acetylglucosaminyltransferase activity,GO:0097363~protein O-acetylglucosaminyltransferase activity,	IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,IPR029489:OGT/SEC/SPY_C,	ocu00514:Other types of O-glycan biosynthesis,ocu03083:Polycomb repressive complex,ocu04931:Insulin resistance,			SM00028:TPR,	KW-0090~Biological rhythms,	KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0677~Repeat,KW-0802~TPR repeat,	KW-0446~Lipid-binding,	KW-0156~Chromatin regulator,KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0007~Acetylation,KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	ACT_SITE:Proton acceptor,CARBOHYD:O-linked (GlcNAc) serine; alternate,CARBOHYD:O-linked (GlcNAc) serine; by autocatalysis,DOMAIN:O-GlcNAc transferase C-terminal,MOTIF:DFP motif,MOTIF:Nuclear localization signal,REGION:Required for phosphatidylinositol 3,4,5-triphosphate binding,REPEAT:TPR,REPEAT:TPR 1,REPEAT:TPR 10,REPEAT:TPR 11,REPEAT:TPR 12,REPEAT:TPR 13; truncated,REPEAT:TPR 2,REPEAT:TPR 3,REPEAT:TPR 4,REPEAT:TPR 5,REPEAT:TPR 6,REPEAT:TPR 7,REPEAT:TPR 8,REPEAT:TPR 9,
Q9NBX4	Probable RNA-directed DNA polymerase from transposon X-element(X-element\ORF2)	Drosophila melanogaster			GO:0006313~DNA transposition,		GO:0003964~RNA-directed DNA polymerase activity,	IPR000477:RT_dom,IPR005135:Endo/exonuclease/phosphatase,IPR036691:Endo/exonu/phosph_ase_sf,IPR043502:DNA/RNA_pol_sf,IPR052560:RdDP_mobile_element,										KW-0548~Nucleotidyltransferase,KW-0695~RNA-directed DNA polymerase,KW-0808~Transferase,		DOMAIN:Reverse transcriptase,REGION:Disordered,
O23657	RAB GTPASE HOMOLOG B18(RAB18)	Arabidopsis thaliana			GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,	GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0010494~cytoplasmic stress granule,GO:0043229~intracellular organelle,	GO:0003924~GTPase activity,GO:0005525~GTP binding,	IPR001806:Small_GTPase,IPR005225:Small_GTP-bd_dom,IPR027417:P-loop_NTPase,IPR050227:Rab,				SM00173:RAS,SM00174:RHO,SM00175:RAB,SM00176:RAN,SM00177:ARF,	KW-0653~Protein transport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,			KW-0342~GTP-binding,KW-0547~Nucleotide-binding,		KW-0007~Acetylation,KW-0449~Lipoprotein,KW-0636~Prenylation,	LIPID:S-geranylgeranyl cysteine,MOTIF:Effector region,REGION:Disordered,
Q9PTY5	RAN binding protein 9 L homeolog(ranbp9.L)	Xenopus laevis				GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,		IPR001870:B30.2/SPRY,IPR003877:SPRY_dom,IPR006594:LisH,IPR006595:CTLH_C,IPR013144:CRA_dom,IPR013320:ConA-like_dom_sf,IPR024964:CTLH/CRA,IPR035782:SPRY_RanBP9/10,IPR043136:B30.2/SPRY_sf,IPR050618:Ubq-SigPath_Reg,				SM00449:SPRY,SM00667:LisH,SM00668:CTLH,SM00757:CRA,		KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-1003~Cell membrane,						DOMAIN:B30.2/SPRY,DOMAIN:CTLH,DOMAIN:LisH,REGION:Disordered,
Q6AYK1	RNA binding protein with serine rich domain 1(Rnps1)	Rattus norvegicus			GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008150~biological_process,GO:0008380~RNA splicing,GO:0043065~positive regulation of apoptotic process,GO:0048025~negative regulation of mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016607~nuclear speck,GO:0061574~ASAP complex,	GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034201:RNPS1_RRM,IPR035979:RBD_domain_sf,	rno03013:Nucleocytoplasmic transport,rno03015:mRNA surveillance pathway,			SM00360:RRM,	KW-0507~mRNA processing,KW-0508~mRNA splicing,KW-0866~Nonsense-mediated mRNA decay,	KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:RRM,REGION:Disordered,REGION:Interaction with SAP18 and ACIN1,REGION:Necessary for interaction with PNN and exon-skipping,REGION:Necessary for interaction with SRP54, nuclear localization and exon-skipping,REGION:Necessary for interaction with TRA2B, nuclear localization and exon-skipping,REGION:Necessary for interaction with the cleaved p110 isoform of CDC2L1,REGION:Necessary for interactions with UPF2 and UPF3B and UPF2-dependent NMD,
P10401, Q8I7P9	RNA-directed DNA polymerase from mobile element jockey(pol)	Drosophila melanogaster			GO:0006313~DNA transposition,GO:0006508~proteolysis,GO:0015074~DNA integration,	GO:0005634~nucleus,GO:0042575~DNA polymerase complex,	GO:0003676~nucleic acid binding,GO:0003964~RNA-directed DNA polymerase activity,GO:0004190~aspartic-type endopeptidase activity,GO:0004519~endonuclease activity,GO:0008233~peptidase activity,GO:0046872~metal ion binding,	IPR000477:RT_dom,IPR001584:Integrase_cat-core,IPR001969:Aspartic_peptidase_AS,IPR005135:Endo/exonuclease/phosphatase,IPR012337:RNaseH-like_sf,IPR013087:Znf_C2H2_type,IPR021109:Peptidase_aspartic_dom_sf,IPR036397:RNaseH_sf,IPR036691:Endo/exonu/phosph_ase_sf,IPR041373:RT_RNaseH,IPR041588:Integrase_H2C2,IPR043128:Rev_trsase/Diguanyl_cyclase,IPR043502:DNA/RNA_pol_sf,IPR050951:Retrovirus_Pol_polyprotein,IPR052560:RdDP_mobile_element,				SM00355:ZnF_C2H2,				KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0064~Aspartyl protease,KW-0255~Endonuclease,KW-0378~Hydrolase,KW-0540~Nuclease,KW-0548~Nucleotidyltransferase,KW-0645~Protease,KW-0695~RNA-directed DNA polymerase,KW-0808~Transferase,		ACT_SITE:For protease activity,DOMAIN:Integrase catalytic,DOMAIN:Reverse transcriptase,REGION:Disordered,ZN_FING:C2H2-type,
Q9VQ29	Rieske iron-sulfur protein(RFeSP)	Drosophila melanogaster			GO:0006122~mitochondrial electron transport, ubiquinol to cytochrome c,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,GO:0045275~respiratory chain complex III,	GO:0008121~ubiquinol-cytochrome-c reductase activity,GO:0016491~oxidoreductase activity,GO:0046872~metal ion binding,GO:0051537~2 iron, 2 sulfur cluster binding,	IPR004192:Rieske_TM,IPR005805:Rieske_Fe-S_prot_C,IPR006317:Ubiquinol_cyt_c_Rdtase_Fe-S-su,IPR014349:Rieske_Fe-S_prot,IPR017941:Rieske_2Fe-2S,IPR036922:Rieske_2Fe-2S_sf,IPR037008:bc1_Rieske_TM_sf,	dme00190:Oxidative phosphorylation,dme01100:Metabolic pathways,dme04148:Efferocytosis,				KW-0249~Electron transport,KW-0679~Respiratory chain,KW-0813~Transport,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,		KW-0809~Transit peptide,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0001~2Fe-2S,KW-0408~Iron,KW-0411~Iron-sulfur,KW-0479~Metal-binding,	KW-0560~Oxidoreductase,KW-1278~Translocase,	KW-1015~Disulfide bond,	DOMAIN:Cytochrome b-c1 complex subunit Rieske transmembrane,DOMAIN:Rieske,REGION:Disordered,TOPO_DOM:Mitochondrial intermembrane,TOPO_DOM:Mitochondrial matrix,TRANSIT:Mitochondrion,TRANSMEM:Helical,
O18405	Surfeit 4(Surf4)	Drosophila melanogaster			GO:0007030~Golgi organization,GO:0015031~protein transport,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0012505~endomembrane system,GO:0016020~membrane,GO:0045169~fusome,		IPR002995:Surf4,IPR045214:Surf1/Surf4,					KW-0653~Protein transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,		KW-0812~Transmembrane,KW-1133~Transmembrane helix,				MOTIF:Di-lysine motif,TRANSMEM:Helical,
Q8C1B2	TCDD-inducible poly(ADP-ribose) polymerase(Tiparp)	Mus musculus			GO:0001570~vasculogenesis,GO:0001822~kidney development,GO:0007588~excretion,GO:0008152~metabolic process,GO:0008209~androgen metabolic process,GO:0008210~estrogen metabolic process,GO:0008585~female gonad development,GO:0009791~post-embryonic development,GO:0010629~negative regulation of gene expression,GO:0030097~hemopoiesis,GO:0045732~positive regulation of protein catabolic process,GO:0048008~platelet-derived growth factor receptor signaling pathway,GO:0048705~skeletal system morphogenesis,GO:0048745~smooth muscle tissue development,GO:0060021~roof of mouth development,GO:0060325~face morphogenesis,GO:0071407~cellular response to organic cyclic compound,GO:1904612~response to 2,3,7,8-tetrachlorodibenzodioxine,	GO:0005634~nucleus,	GO:0000987~cis-regulatory region sequence-specific DNA binding,GO:0003950~NAD+-protein poly-ADP-ribosyltransferase activity,GO:0016779~nucleotidyltransferase activity,GO:0046872~metal ion binding,GO:0140803~NAD+-protein-cysteine ADP-ribosyltransferase activity,GO:0140806~NAD+-protein-aspartate ADP-ribosyltransferase activity,GO:0140822~NAD+-histone H2BE35 glutamate ADP-ribosyltransferase activity,GO:0140844~NAD+-histone H2BE2 glutamate ADP-ribosyltransferase activity,GO:0140867~NAD+-histone H2BE18 glutamate ADP-ribosyltransferase activity,GO:1990404~NAD+-protein ADP-ribosyltransferase activity,	IPR000571:Znf_CCCH,IPR004170:WWE_dom,IPR012317:Poly(ADP-ribose)pol_cat_dom,IPR037197:WWE_dom_sf,IPR051712:ARTD-AVP,						KW-0539~Nucleus,		KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0520~NAD,KW-0862~Zinc,	KW-0328~Glycosyltransferase,KW-0548~Nucleotidyltransferase,KW-0808~Transferase,	KW-0013~ADP-ribosylation,	DOMAIN:C3H1-type,DOMAIN:PARP catalytic,DOMAIN:WWE,MOTIF:Nuclear localization signal,REGION:Disordered,ZN_FING:C3H1-type,
Q9JIT3	TLE family member 3, transcriptional corepressor(Tle3)	Rattus norvegicus			GO:0006355~regulation of DNA-templated transcription,GO:0016055~Wnt signaling pathway,GO:0045892~negative regulation of DNA-templated transcription,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0120163~negative regulation of cold-induced thermogenesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription regulator complex,GO:1990907~beta-catenin-TCF complex,	GO:0003714~transcription corepressor activity,GO:0005515~protein binding,	IPR001680:WD40_rpt,IPR005617:Groucho/TLE_N,IPR009146:Groucho_enhance,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR019775:WD40_repeat_CS,IPR036322:WD40_repeat_dom_sf,	rno04310:Wnt signaling pathway,rno04330:Notch signaling pathway,			SM00320:WD40,	KW-0804~Transcription,KW-0805~Transcription regulation,KW-0879~Wnt signaling pathway,	KW-0539~Nucleus,		KW-0175~Coiled coil,KW-0677~Repeat,KW-0853~WD repeat,		KW-0678~Repressor,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:Groucho/TLE N-terminal Q-rich,MOTIF:Nuclear localization signal,REGION:CcN domain,REGION:Disordered,REGION:GP domain,REGION:Q domain,REGION:SP domain,REPEAT:WD,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,
Q60803	TNF receptor-associated factor 3(Traf3)	Mus musculus	m_cd40Pathway:CD40L Signaling Pathway,m_tall1Pathway:TACI and BCMA stimulation of B cell immune responses.,m_tnfr2Pathway:TNFR2 Signaling Pathway,	Cell division and chromosome partitioning,	GO:0001817~regulation of cytokine production,GO:0002224~toll-like receptor signaling pathway,GO:0006915~apoptotic process,GO:0007166~cell surface receptor signaling pathway,GO:0008063~Toll signaling pathway,GO:0030162~regulation of proteolysis,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032481~positive regulation of type I interferon production,GO:0032648~regulation of interferon-beta production,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0034142~toll-like receptor 4 signaling pathway,GO:0042981~regulation of apoptotic process,GO:0043122~regulation of canonical NF-kappaB signal transduction,GO:0045087~innate immune response,GO:0050688~regulation of defense response to virus,GO:0070534~protein K63-linked ubiquitination,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005768~endosome,GO:0009898~cytoplasmic side of plasma membrane,GO:0010008~endosome membrane,GO:0035631~CD40 receptor complex,GO:0098802~plasma membrane signaling receptor complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005164~tumor necrosis factor receptor binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0019901~protein kinase binding,GO:0019903~protein phosphatase binding,GO:0031625~ubiquitin protein ligase binding,GO:0031996~thioesterase binding,GO:0035591~signaling adaptor activity,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR001293:Znf_TRAF,IPR001841:Znf_RING,IPR002083:MATH/TRAF_dom,IPR008974:TRAF-like,IPR012227:TNF_rcpt-assoc_TRAF_met,IPR013083:Znf_RING/FYVE/PHD,IPR017907:Znf_RING_CS,IPR027128:TRAF3_RING-HC,IPR037304:TRAF3_MATH,IPR049342:TRAF1-6_MATH_dom,IPR049440:TRAF3/5_RING,	mmu04064:NF-kappa B signaling pathway,mmu04620:Toll-like receptor signaling pathway,mmu04621:NOD-like receptor signaling pathway,mmu04622:RIG-I-like receptor signaling pathway,mmu04657:IL-17 signaling pathway,mmu04668:TNF signaling pathway,mmu04936:Alcoholic liver disease,mmu05160:Hepatitis C,mmu05161:Hepatitis B,mmu05162:Measles,mmu05164:Influenza A,mmu05165:Human papillomavirus infection,mmu05167:Kaposi sarcoma-associated herpesvirus infection,mmu05168:Herpes simplex virus 1 infection,mmu05169:Epstein-Barr virus infection,mmu05171:Coronavirus disease - COVID-19,mmu05200:Pathways in cancer,mmu05203:Viral carcinogenesis,mmu05222:Small cell lung cancer,mmu05417:Lipid and atherosclerosis,		PIRSF015614:TRAF,	SM00061:MATH,	KW-0053~Apoptosis,KW-0391~Immunity,KW-0833~Ubl conjugation pathway,	KW-0496~Mitochondrion,KW-0963~Cytoplasm,KW-0967~Endosome,		KW-0175~Coiled coil,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0808~Transferase,	KW-0832~Ubl conjugation,KW-0882~Thioester bond,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl cysteine thioester (Cys-Gly) (interchain with G-Cter in ubiquitin),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:MATH,DOMAIN:RING-type,DOMAIN:TRAF-type,MUTAGEN:C->A: Abolishes inhibition of NFKB2 processing; when associated with A-52.,MUTAGEN:C->A: Abolishes inhibition of NFKB2 processing; when associated with A-55.,MUTAGEN:C->A: Strongly reduces 'Lys-63'-linked ubiquitination; when associated with A-69. Abolishes inhibition of NFKB2 processing; when associated with A-69.,MUTAGEN:F->Y: Loss of interaction with MAVS.,MUTAGEN:H->A: Strongly reduces 'Lys-63'-linked ubiquitination; when associated with A-69. Abolishes inhibition of NFKB2 processing; when associated with A-67.,MUTAGEN:K->R: Abolished ubiquitination by the SCF(FBXL2) complex.,MUTAGEN:K->R: Reduces 'Lys-48'-linked polyubiquitination; when associated with R-106.,MUTAGEN:K->R: Reduces 'Lys-48'-linked polyubiquitination; when associated with R-155.,MUTAGEN:W->A: Decreased interaction with FBXL2.,MUTAGEN:Y->F: Loss of interaction with MAVS.,REGION:Disordered,ZN_FING:RING-type,ZN_FING:TRAF-type,ZN_FING:TRAF-type 1,ZN_FING:TRAF-type 2,
P14381	Transposon TX1 uncharacterized 149 kDa protein (YTX2_XENLA)	Xenopus laevis					GO:0003824~catalytic activity,	IPR000477:RT_dom,IPR005135:Endo/exonuclease/phosphatase,IPR036691:Endo/exonu/phosph_ase_sf,IPR043502:DNA/RNA_pol_sf,IPR052343:Retrotransposon-Effector_Assoc,												DOMAIN:Reverse transcriptase,
P36514	UDP-glucuronosyltransferase(UGT2C1)	Oryctolagus cuniculus			GO:0006629~lipid metabolic process,	GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,	GO:0008194~UDP-glycosyltransferase activity,GO:0015020~glucuronosyltransferase activity,	IPR002213:UDP_glucos_trans,IPR035595:UDP_glycos_trans_CS,IPR050271:UDP-glycosyltransferase,	ocu00040:Pentose and glucuronate interconversions,ocu00053:Ascorbate and aldarate metabolism,ocu00140:Steroid hormone biosynthesis,ocu00830:Retinol metabolism,ocu00860:Porphyrin metabolism,ocu00980:Metabolism of xenobiotics by cytochrome P450,ocu00982:Drug metabolism - cytochrome P450,ocu00983:Drug metabolism - other enzymes,ocu01100:Metabolic pathways,ocu01240:Biosynthesis of cofactors,ocu04976:Bile secretion,ocu05204:Chemical carcinogenesis - DNA adducts,ocu05207:Chemical carcinogenesis - receptor activation,				KW-0443~Lipid metabolism,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0492~Microsome,		KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,TRANSMEM:Helical,
B2RZ78	VPS29 retromer complex component(Vps29)	Rattus norvegicus			GO:0006886~intracellular protein transport,GO:0008150~biological_process,GO:0015031~protein transport,GO:0032456~endocytic recycling,GO:0042147~retrograde transport, endosome to Golgi,	GO:0005768~endosome,GO:0005769~early endosome,GO:0005770~late endosome,GO:0005829~cytosol,GO:0010008~endosome membrane,GO:0030904~retromer complex,GO:0030906~retromer, cargo-selective complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0046872~metal ion binding,	IPR000979:Phosphodiesterase_MJ0936/Vps29,IPR024654:Calcineurin-like_PHP_lpxH,IPR028661:Vps29,IPR029052:Metallo-depent_PP-like,	rno04144:Endocytosis,				KW-0653~Protein transport,KW-0813~Transport,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-0967~Endosome,			KW-0479~Metal-binding,KW-0862~Zinc,		KW-0007~Acetylation,	DOMAIN:Calcineurin-like phosphoesterase,
P20107	Zn(2+) transporter ZRC1(ZRC1)	Saccharomyces cerevisiae S288C			GO:0006811~monoatomic ion transport,GO:0006812~monoatomic cation transport,GO:0006829~zinc ion transport,GO:0006882~intracellular zinc ion homeostasis,GO:0030003~intracellular monoatomic cation homeostasis,GO:0046686~response to cadmium ion,GO:0055085~transmembrane transport,GO:0071577~zinc ion transmembrane transport,GO:0098771~inorganic ion homeostasis,	GO:0000324~fungal-type vacuole,GO:0000329~fungal-type vacuole membrane,GO:0005773~vacuole,GO:0005774~vacuolar membrane,GO:0016020~membrane,GO:0045121~membrane raft,	GO:0005385~zinc ion transmembrane transporter activity,GO:0008270~zinc ion binding,GO:0008324~monoatomic cation transmembrane transporter activity,	IPR002524:Cation_efflux,IPR027469:Cation_efflux_TMD_sf,IPR036837:Cation_efflux_CTD_sf,					KW-0105~Cadmium resistance,KW-0406~Ion transport,KW-0813~Transport,KW-0864~Zinc transport,	KW-0472~Membrane,KW-0926~Vacuole,		KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0104~Cadmium,KW-0862~Zinc,		KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),MOTIF:Histidine repeat 1,MOTIF:Histidine repeat 2,MOTIF:Histidine repeat 3,MUTAGEN:N->I: Changed the substrate specificity of the transporter from zinc to iron.,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Vacuolar,TRANSMEM:Helical,
Q5ZMP6	adaptor related protein complex 2 mu 1 subunit(AP2M1)	Gallus gallus			GO:0006886~intracellular protein transport,GO:0006897~endocytosis,GO:0072583~clathrin-dependent endocytosis,	GO:0005886~plasma membrane,GO:0005905~clathrin-coated pit,GO:0030122~AP-2 adaptor complex,GO:0030131~clathrin adaptor complex,GO:0031410~cytoplasmic vesicle,	GO:0008289~lipid binding,GO:0035615~clathrin adaptor activity,	IPR001392:Clathrin_mu,IPR011012:Longin-like_dom_sf,IPR018240:Clathrin_mu_CS,IPR022775:AP_mu_sigma_su,IPR028565:MHD,IPR036168:AP2_Mu_C_sf,IPR043512:Mu2_C,IPR043532:AP2_Mu_N,IPR050431:Adaptor_comp_med_subunit,	gga04144:Endocytosis,		PIRSF005992:Clathrin_mu,		KW-0254~Endocytosis,KW-0653~Protein transport,KW-0813~Transport,	KW-0168~Coated pit,KW-0472~Membrane,KW-1003~Cell membrane,			KW-0446~Lipid-binding,			DOMAIN:MHD,
Q9NYQ7	cadherin EGF LAG seven-pass G-type receptor 3(CELSR3)	Homo sapiens			GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007186~G protein-coupled receptor signaling pathway,GO:0036514~dopaminergic neuron axon guidance,GO:0036515~serotonergic neuron axon guidance,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,GO:0098609~cell-cell adhesion,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004930~G protein-coupled receptor activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR000203:GPS,IPR000742:EGF-like_dom,IPR000832:GPCR_2_secretin-like,IPR001791:Laminin_G,IPR001879:GPCR_2_extracellular_dom,IPR001881:EGF-like_Ca-bd_dom,IPR002049:LE_dom,IPR002126:Cadherin-like_dom,IPR013320:ConA-like_dom_sf,IPR015919:Cadherin-like_sf,IPR017981:GPCR_2-like_7TM,IPR017983:GPCR_2_secretin-like_CS,IPR020894:Cadherin_CS,IPR032471:GAIN_dom_N,IPR036445:GPCR_2_extracell_dom_sf,IPR046338:GAIN_dom_sf,				SM00008:HormR,SM00112:CA,SM00179:EGF_CA,SM00180:EGF_Lam,SM00181:EGF,SM00282:LamG,SM00303:GPS,		KW-0472~Membrane,KW-1003~Cell membrane,		KW-0245~EGF-like domain,KW-0424~Laminin EGF-like domain,KW-0677~Repeat,KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,	KW-0217~Developmental protein,KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,KW-9996~Developmental protein,	KW-0325~Glycoprotein,KW-0379~Hydroxylation,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:Cadherin 1,DOMAIN:Cadherin 2,DOMAIN:Cadherin 3,DOMAIN:Cadherin 4,DOMAIN:Cadherin 5,DOMAIN:Cadherin 6,DOMAIN:Cadherin 7,DOMAIN:Cadherin 8,DOMAIN:Cadherin 9,DOMAIN:EGF-like 1; calcium-binding,DOMAIN:EGF-like 2; calcium-binding,DOMAIN:EGF-like 3; calcium-binding,DOMAIN:EGF-like 4; calcium-binding,DOMAIN:EGF-like 5; calcium-binding,DOMAIN:EGF-like 6; calcium-binding,DOMAIN:EGF-like 7; calcium-binding,DOMAIN:EGF-like 8; calcium-binding,DOMAIN:GAIN-B,DOMAIN:Laminin EGF-like,DOMAIN:Laminin G-like 1,DOMAIN:Laminin G-like 2,REGION:Disordered,REGION:GPS,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
Q4R4R6	cell division cycle 42(CDC42)	Macaca fascicularis			GO:0006897~endocytosis,GO:0006911~phagocytosis, engulfment,GO:0007015~actin filament organization,GO:0007163~establishment or maintenance of cell polarity,GO:0007399~nervous system development,GO:0009653~anatomical structure morphogenesis,GO:0030154~cell differentiation,GO:0032467~positive regulation of cytokinesis,GO:0032488~Cdc42 protein signal transduction,GO:0048549~positive regulation of pinocytosis,GO:0051130~positive regulation of cellular component organization,GO:0051301~cell division,GO:0051489~regulation of filopodium assembly,GO:0051988~regulation of attachment of spindle microtubules to kinetochore,GO:0099563~modification of synaptic structure,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030496~midbody,GO:0031258~lamellipodium membrane,GO:0043197~dendritic spine,GO:0043227~membrane-bounded organelle,GO:0051233~spindle midzone,GO:0072686~mitotic spindle,	GO:0003924~GTPase activity,GO:0003925~G protein activity,GO:0005525~GTP binding,GO:0019901~protein kinase binding,	IPR001806:Small_GTPase,IPR003578:Small_GTPase_Rho,IPR005225:Small_GTP-bd_dom,IPR027417:P-loop_NTPase,IPR037874:Cdc42,	mcf04010:MAPK signaling pathway,mcf04014:Ras signaling pathway,mcf04015:Rap1 signaling pathway,mcf04062:Chemokine signaling pathway,mcf04144:Endocytosis,mcf04360:Axon guidance,mcf04370:VEGF signaling pathway,mcf04510:Focal adhesion,mcf04520:Adherens junction,mcf04530:Tight junction,mcf04660:T cell receptor signaling pathway,mcf04666:Fc gamma R-mediated phagocytosis,mcf04670:Leukocyte transendothelial migration,mcf04722:Neurotrophin signaling pathway,mcf04810:Regulation of actin cytoskeleton,mcf04912:GnRH signaling pathway,mcf04932:Non-alcoholic fatty liver disease,mcf04933:AGE-RAGE signaling pathway in diabetic complications,mcf05100:Bacterial invasion of epithelial cells,mcf05132:Salmonella infection,mcf05135:Yersinia infection,mcf05165:Human papillomavirus infection,mcf05200:Pathways in cancer,mcf05203:Viral carcinogenesis,mcf05205:Proteoglycans in cancer,mcf05211:Renal cell carcinoma,mcf05212:Pancreatic cancer,mcf05417:Lipid and atherosclerosis,			SM00173:RAS,SM00174:RHO,SM00175:RAB,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0221~Differentiation,KW-0524~Neurogenesis,	KW-0206~Cytoskeleton,KW-0472~Membrane,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-1003~Cell membrane,			KW-0342~GTP-binding,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,	KW-0449~Lipoprotein,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0636~Prenylation,	LIPID:S-geranylgeranyl cysteine,MOTIF:Effector region,PROPEP:Removed in mature form,
Q922M5	cell division cycle associated 7 like(Cdca7l)	Mus musculus			GO:0006355~regulation of DNA-templated transcription,GO:0008284~positive regulation of cell population proliferation,	GO:0001650~fibrillar center,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005829~cytosol,		IPR018866:Znf-4CXXC_R1,IPR040221:CDCA7/CDA7L,					KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0678~Repressor,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),MOTIF:Integrase domain-binding motif 1 (IBM1),MOTIF:Integrase domain-binding motif 2 (IBM2),REGION:Disordered,REGION:MYC-binding,REGION:PSIP1-binding,
Q6EE31	chaperonin containing TCP1 subunit 8(CCT8)	Gallus gallus			GO:0006457~protein folding,	GO:0005813~centrosome,GO:0005832~chaperonin-containing T-complex,GO:0005856~cytoskeleton,GO:0042995~cell projection,	GO:0005524~ATP binding,GO:0016887~ATP hydrolysis activity,GO:0051082~unfolded protein binding,GO:0140662~ATP-dependent protein folding chaperone,	IPR002194:Chaperonin_TCP-1_CS,IPR002423:Cpn60/GroEL/TCP-1,IPR012721:Chap_CCT_theta,IPR017998:Chaperone_TCP-1,IPR027409:GroEL-like_apical_dom_sf,IPR027410:TCP-1-like_intermed_sf,IPR027413:GROEL-like_equatorial_sf,						KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0966~Cell projection,			KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0143~Chaperone,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	REGION:Disordered,
Q8WP19	cryptochrome circadian regulator 1(CRY1)	Macaca fascicularis			GO:0000122~negative regulation of transcription by RNA polymerase II,GO:0006094~gluconeogenesis,GO:0007623~circadian rhythm,GO:0009416~response to light stimulus,GO:0014823~response to activity,GO:0019915~lipid storage,GO:0031397~negative regulation of protein ubiquitination,GO:0031398~positive regulation of protein ubiquitination,GO:0032868~response to insulin,GO:0032922~circadian regulation of gene expression,GO:0033762~response to glucagon,GO:0042593~glucose homeostasis,GO:0042752~regulation of circadian rhythm,GO:0042754~negative regulation of circadian rhythm,GO:0042770~signal transduction in response to DNA damage,GO:0043153~entrainment of circadian clock by photoperiod,GO:0045721~negative regulation of gluconeogenesis,GO:0045722~positive regulation of gluconeogenesis,GO:0045744~negative regulation of G protein-coupled receptor signaling pathway,GO:0045892~negative regulation of DNA-templated transcription,GO:2000001~regulation of DNA damage checkpoint,GO:2000323~negative regulation of glucocorticoid receptor signaling pathway,GO:2000850~negative regulation of glucocorticoid secretion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,	GO:0003677~DNA binding,GO:0009881~photoreceptor activity,GO:0016922~nuclear receptor binding,GO:0019901~protein kinase binding,GO:0019902~phosphatase binding,GO:0042826~histone deacetylase binding,GO:0070888~E-box binding,GO:0071949~FAD binding,	IPR002081:Cryptochrome/DNA_photolyase_1,IPR005101:Cryptochr/Photolyase_FAD-bd,IPR006050:DNA_photolyase_N,IPR014729:Rossmann-like_a/b/a_fold,IPR036134:Crypto/Photolyase_FAD-like_sf,IPR036155:Crypto/Photolyase_N_sf,	mcf04710:Circadian rhythm,				KW-0090~Biological rhythms,KW-0716~Sensory transduction,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0157~Chromophore,KW-0274~FAD,KW-0285~Flavoprotein,KW-0547~Nucleotide-binding,	KW-0600~Photoreceptor protein,KW-0675~Receptor,KW-0678~Repressor,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:Photolyase/cryptochrome alpha/beta,MOTIF:LIR 1,MOTIF:LIR 10,MOTIF:LIR 11,MOTIF:LIR 12,MOTIF:LIR 13,MOTIF:LIR 2,MOTIF:LIR 3,MOTIF:LIR 4,MOTIF:LIR 5,MOTIF:LIR 6,MOTIF:LIR 7,MOTIF:LIR 8,MOTIF:LIR 9,REGION:Disordered,REGION:Interaction with TIMELESS,REGION:Required for inhibition of CLOCK-BMAL1-mediated transcription,SITE:Electron transfer via tryptophanyl radical,
Q9R194	cryptochrome circadian regulator 2(Cry2)	Mus musculus	m_circadianPathway:Circadian Rhythms,	DNA replication, recombination, and repair,	GO:0000122~negative regulation of transcription by RNA polymerase II,GO:0006606~protein import into nucleus,GO:0007623~circadian rhythm,GO:0009416~response to light stimulus,GO:0014823~response to activity,GO:0019915~lipid storage,GO:0032868~response to insulin,GO:0032922~circadian regulation of gene expression,GO:0042593~glucose homeostasis,GO:0042752~regulation of circadian rhythm,GO:0042754~negative regulation of circadian rhythm,GO:0043153~entrainment of circadian clock by photoperiod,GO:0045892~negative regulation of DNA-templated transcription,GO:2000118~regulation of sodium-dependent phosphate transport,GO:2000323~negative regulation of glucocorticoid receptor signaling pathway,GO:2000850~negative regulation of glucocorticoid secretion,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0016607~nuclear speck,GO:1990512~Cry-Per complex,	GO:0000976~transcription cis-regulatory region binding,GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003697~single-stranded DNA binding,GO:0004864~protein phosphatase inhibitor activity,GO:0005515~protein binding,GO:0009881~photoreceptor activity,GO:0016922~nuclear receptor binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0019902~phosphatase binding,GO:0071949~FAD binding,	IPR002081:Cryptochrome/DNA_photolyase_1,IPR005101:Cryptochr/Photolyase_FAD-bd,IPR006050:DNA_photolyase_N,IPR014729:Rossmann-like_a/b/a_fold,IPR036134:Crypto/Photolyase_FAD-like_sf,IPR036155:Crypto/Photolyase_N_sf,	mmu04710:Circadian rhythm,				KW-0090~Biological rhythms,KW-0716~Sensory transduction,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0157~Chromophore,KW-0274~FAD,KW-0285~Flavoprotein,KW-0547~Nucleotide-binding,	KW-0600~Photoreceptor protein,KW-0675~Receptor,KW-0678~Repressor,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:Cryptochrome/DNA photolyase FAD-binding,DOMAIN:Photolyase/cryptochrome alpha/beta,MUTAGEN:D->R: Strongly reduces PER1 binding.,MUTAGEN:F->D: Abolishes binding of FBXL3 and SKP1. Strongly decreases CRY2 degradation.,MUTAGEN:G->D: Loss of ability to inhibit CLOCK-BMAL1-mediated transcriptional activity. No loss of ability to inhibit NR1I2 transcriptional activity.,MUTAGEN:I->D: Abolishes binding of FBXL3 and SKP1. Strongly decreases CRY2 degradation.,MUTAGEN:K->R: Inhibits interaction with PER2. Does not suppress its nuclear localization. Inhibits its repression activity on CLOCK|NPAS2-BMAL1-driven transcription.,MUTAGEN:L->D: Decreases FBXL3 binding. Strongly decreases CRY2 degradation.,MUTAGEN:R->A: Impairs protein folding. Abolishes binding of BMAL1, PER1 and FBXL3. Strongly reduces SKP1 binding.,MUTAGEN:R->K: Reduced interaction with NR1I2 and NR1I3. Significant decrease in interaction with NR1I2 and NR1I3; when associated with E-394 and M-396.,MUTAGEN:R->Q: Inhibits interaction with PER2. Does not suppress its nuclear localization. Inhibits its repression activity on CLOCK|NPAS2-BMAL1-driven transcription.,MUTAGEN:S->A: Reduced in vitro MAPK-catalyzed phosphorylation. No effect on inhibition of CLOCK-BMAL1-mediated transcriptional activity. Very little in vitro MAPK-catalyzed phosphorylation; when associated with A-265. Shorter circadian rhythm; when associated with A-553.,MUTAGEN:S->A: Reduced in vitro MAPK-catalyzed phosphorylation. No effect on inhibition of CLOCK-BMAL1-mediated transcriptional activity. Very little in vitro MAPK-catalyzed phosphorylation; when associated with A-557.,MUTAGEN:S->A: Shorter circadian rhythm; when associated with A-557.,MUTAGEN:S->D: Reduced inhibition of CLOCK-BMAL1-mediated transcriptional activity. No effect on nuclear localization nor on protein stability.,MUTAGEN:S->E: Reduced interaction with NR1I2 and NR1I3. Significant decrease in interaction with NR1I2 and NR1I3; when associated with M-396 and K-397.,MUTAGEN:V->M: Reduced interaction with NR1I2 and NR1I3. Significant decrease in interaction with NR1I2 and NR1I3; when associated with E-394 and K-397.,MUTAGEN:W->A: Decreases FBXL3 binding. Strongly decreases CRY2 degradation.,REGION:Disordered,REGION:Required for inhibition of CLOCK-BMAL1-mediated transcription,
O42412	deiodinase, iodothyronine type III(DIO3)	Gallus gallus			GO:0042403~thyroid hormone metabolic process,GO:0042446~hormone biosynthetic process,	GO:0005886~plasma membrane,GO:0010008~endosome membrane,	GO:0004800~thyroxine 5'-deiodinase activity,GO:0033798~thyroxine 5-deiodinase activity,	IPR000643:Iodothyronine_deiodinase,IPR008261:Iodothyronine_deiodinase_AS,IPR027252:Iodothyronine_deiodinase_I/III,IPR036249:Thioredoxin-like_sf,			PIRSF001330:IOD,PIRSF500144:IODI_III,		KW-0893~Thyroid hormones biosynthesis,	KW-0472~Membrane,KW-0967~Endosome,KW-1003~Cell membrane,		KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0560~Oxidoreductase,		NON_STD:Selenocysteine,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q6R5J2	dispatched homolog 1 (Drosophila)(disp1)	Danio rerio			GO:0007224~smoothened signaling pathway,GO:0007519~skeletal muscle tissue development,GO:0008015~blood circulation,GO:0009887~animal organ morphogenesis,GO:0009952~anterior/posterior pattern specification,GO:0021984~adenohypophysis development,GO:0031290~retinal ganglion cell axon guidance,GO:0042694~muscle cell fate specification,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0048839~inner ear development,	GO:0016020~membrane,	GO:1904680~peptide transmembrane transporter activity,	IPR000731:SSD,IPR003392:Ptc/Disp,IPR052081:Dispatched_Hh_regulator,	dre04340:Hedgehog signaling pathway,					KW-0472~Membrane,		KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Polar residues,DOMAIN:SSD,REGION:Disordered,TRANSMEM:Helical,
Q15370	elongin B(ELOB)	Homo sapiens			GO:0006367~transcription initiation at RNA polymerase II promoter,GO:0006368~transcription elongation by RNA polymerase II,GO:0016567~protein ubiquitination,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0065003~protein-containing complex assembly,GO:0140958~target-directed miRNA degradation,	GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0030891~VCB complex,GO:0031462~Cul2-RING ubiquitin ligase complex,GO:0031466~Cul5-RING ubiquitin ligase complex,GO:0070449~elongin complex,	GO:0001222~transcription corepressor binding,GO:0003746~translation elongation factor activity,GO:0005515~protein binding,GO:0031625~ubiquitin protein ligase binding,	IPR000626:Ubiquitin-like_dom,IPR029071:Ubiquitin-like_domsf,IPR039049:ELOB,	hsa04066:HIF-1 signaling pathway,hsa04120:Ubiquitin mediated proteolysis,hsa05170:Human immunodeficiency virus 1 infection,hsa05200:Pathways in cancer,hsa05211:Renal cell carcinoma,			SM00213:UBQ,	KW-0648~Protein biosynthesis,KW-0804~Transcription,KW-0805~Transcription regulation,KW-0833~Ubl conjugation pathway,KW-0945~Host-virus interaction,	KW-0539~Nucleus,				KW-0251~Elongation factor,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Ubiquitin-like,REGION:Disordered,
Q90705	eukaryotic translation elongation factor 2(EEF2)	Gallus gallus		Translation, ribosomal structure and biogenesis,	GO:0006412~translation,GO:0006414~translational elongation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:1990904~ribonucleoprotein complex,	GO:0003746~translation elongation factor activity,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0043022~ribosome binding,	IPR000640:EFG_V-like,IPR000795:T_Tr_GTP-bd_dom,IPR004161:EFTu-like_2,IPR005225:Small_GTP-bd_dom,IPR005517:Transl_elong_EFG/EF2_IV,IPR009000:Transl_B-barrel_sf,IPR014721:Ribsml_uS5_D2-typ_fold_subgr,IPR020568:Ribosomal_Su5_D2-typ_SF,IPR027417:P-loop_NTPase,IPR031157:G_TR_CS,IPR035647:EFG_III/V,IPR041095:EFG_II,				SM00838:EFG_C,SM00889:EFG_IV,	KW-0648~Protein biosynthesis,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0342~GTP-binding,KW-0547~Nucleotide-binding,	KW-0251~Elongation factor,KW-0378~Hydrolase,	KW-0597~Phosphoprotein,	DOMAIN:Tr-type G,DOMAIN:tr-type G,REGION:Disordered,
Q80U96	exportin 1(Xpo1)	Rattus norvegicus		Nuclear structure / Intracellular trafficking and secretion,	GO:0000054~ribosomal subunit export from nucleus,GO:0000055~ribosomal large subunit export from nucleus,GO:0000056~ribosomal small subunit export from nucleus,GO:0000122~negative regulation of transcription by RNA polymerase II,GO:0006406~mRNA export from nucleus,GO:0006611~protein export from nucleus,GO:0006913~nucleocytoplasmic transport,GO:0009410~response to xenobiotic stimulus,GO:0010824~regulation of centrosome duplication,GO:0032434~regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0034504~protein localization to nucleus,GO:0042176~regulation of protein catabolic process,GO:0042254~ribosome biogenesis,GO:0046825~regulation of protein export from nucleus,GO:0071401~cellular response to triglyceride,GO:1902075~cellular response to salt,	GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005642~annulate lamellae,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0015030~Cajal body,GO:0031965~nuclear membrane,GO:0032991~protein-containing complex,GO:0043231~intracellular membrane-bounded organelle,GO:1990904~ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0005049~nuclear export signal receptor activity,GO:0005515~protein binding,GO:0019904~protein domain specific binding,GO:0031267~small GTPase binding,GO:0140297~DNA-binding transcription factor binding,	IPR001494:Importin-beta_N,IPR011989:ARM-like,IPR013598:Exportin-1/Importin-b-like,IPR014877:XPO1_C_dom,IPR016024:ARM-type_fold,IPR040485:XPO1_repeat_3,IPR041123:CRM1_repeat,IPR041235:Exp1_repeat_2,IPR045065:XPO1/5,	rno03008:Ribosome biogenesis in eukaryotes,rno03013:Nucleocytoplasmic transport,rno03250:Viral life cycle - HIV-1,rno05164:Influenza A,rno05166:Human T-cell leukemia virus 1 infection,			SM00913:IBN_N,SM01102:CRM1_C,	KW-0509~mRNA transport,KW-0653~Protein transport,KW-0813~Transport,	KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0677~Repeat,		KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Exportin-1 C-terminal,DOMAIN:Importin N-terminal,REGION:Necessary for interaction with RANBP3,REGION:Necessary for interaction with Ran and nuclear export complex formation,REPEAT:HEAT 1,REPEAT:HEAT 10,REPEAT:HEAT 2,REPEAT:HEAT 3,REPEAT:HEAT 4,REPEAT:HEAT 5,REPEAT:HEAT 6,REPEAT:HEAT 7,REPEAT:HEAT 8,REPEAT:HEAT 9,
Q99315	gag-pol fusion protein(YGR109W-B)	Saccharomyces cerevisiae S288C			GO:0006278~RNA-templated DNA biosynthetic process,GO:0006310~DNA recombination,GO:0006508~proteolysis,GO:0015074~DNA integration,GO:0032197~retrotransposition,GO:0071897~DNA biosynthetic process,GO:0075523~viral translational frameshifting,	GO:0000943~retrotransposon nucleocapsid,GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003720~telomerase activity,GO:0003723~RNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0003964~RNA-directed DNA polymerase activity,GO:0004190~aspartic-type endopeptidase activity,GO:0004519~endonuclease activity,GO:0004523~RNA-DNA hybrid ribonuclease activity,GO:0004540~RNA nuclease activity,GO:0005524~ATP binding,GO:0008233~peptidase activity,GO:0008270~zinc ion binding,GO:0034061~DNA polymerase activity,GO:0046872~metal ion binding,	IPR000477:RT_dom,IPR001584:Integrase_cat-core,IPR001878:Znf_CCHC,IPR012337:RNaseH-like_sf,IPR021109:Peptidase_aspartic_dom_sf,IPR024650:Peptidase_A2B,IPR036397:RNaseH_sf,IPR036875:Znf_CCHC_sf,IPR041577:RT_RNaseH_2,IPR041588:Integrase_H2C2,IPR043128:Rev_trsase/Diguanyl_cyclase,IPR043502:DNA/RNA_pol_sf,IPR045358:Ty3_capsid,IPR050951:Retrovirus_Pol_polyprotein,				SM00343:ZnF_C2HC,	KW-0229~DNA integration,KW-0233~DNA recombination,KW-0917~Virion maturation,KW-1188~Viral release from host cell,	KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0863~Zinc-finger,	KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,KW-0862~Zinc,	KW-0064~Aspartyl protease,KW-0238~DNA-binding,KW-0239~DNA-directed DNA polymerase,KW-0255~Endonuclease,KW-0378~Hydrolase,KW-0511~Multifunctional enzyme,KW-0540~Nuclease,KW-0548~Nucleotidyltransferase,KW-0645~Protease,KW-0694~RNA-binding,KW-0695~RNA-directed DNA polymerase,KW-0808~Transferase,	KW-0007~Acetylation,	ACT_SITE:For protease activity; shared with dimeric partner,DOMAIN:Integrase catalytic,DOMAIN:RNase H Ty3/gyspy-type,DOMAIN:Reverse transcriptase,MUTAGEN:C->S: Reduces level of VLP formation and maturation.,MUTAGEN:H->Q: Reduces level of VLP formation and maturation.,PEPTIDE:Spacer peptide J,PEPTIDE:Spacer peptide p3,REGION:Integrase-type zinc finger-like,SITE:Cleavage; by Ty3 protease,SITE:Cleavage; by Ty3 protease; partial,ZN_FING:CCHC-type,
P47742	gamma-aminobutyric acid type A receptor subunit rho 2(Gabrr2)	Rattus norvegicus			GO:0007165~signal transduction,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0007268~chemical synaptic transmission,GO:0007601~visual perception,GO:0042391~regulation of membrane potential,GO:0050877~nervous system process,GO:0060078~regulation of postsynaptic membrane potential,GO:1902476~chloride transmembrane transport,	GO:0005886~plasma membrane,GO:0034707~chloride channel complex,GO:0043005~neuron projection,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0097708~intracellular vesicle,GO:0098982~GABA-ergic synapse,GO:1902495~transmembrane transporter complex,GO:1902711~GABA-A receptor complex,	GO:0004890~GABA-A receptor activity,GO:0005230~extracellular ligand-gated monoatomic ion channel activity,GO:0005237~inhibitory extracellular ligand-gated monoatomic ion channel activity,GO:0005254~chloride channel activity,GO:0019904~protein domain specific binding,GO:0022851~GABA-gated chloride ion channel activity,GO:0030594~neurotransmitter receptor activity,GO:1904315~transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential,	IPR006028:GABAA/Glycine_rcpt,IPR006029:Neurotrans-gated_channel_TM,IPR006201:Neur_channel,IPR006202:Neur_chan_lig-bd,IPR008057:GABAAa_rho_rcpt,IPR008059:GABAAa_rho2_rcpt,IPR018000:Neurotransmitter_ion_chnl_CS,IPR036719:Neuro-gated_channel_TM_sf,IPR036734:Neur_chan_lig-bd_sf,IPR038050:Neuro_actylchol_rec,	rno04080:Neuroactive ligand-receptor interaction,rno04723:Retrograde endocannabinoid signaling,rno04727:GABAergic synapse,rno05032:Morphine addiction,rno05033:Nicotine addiction,				KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-0628~Postsynaptic cell membrane,KW-0770~Synapse,KW-1003~Cell membrane,		KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0868~Chloride,	KW-0407~Ion channel,KW-0869~Chloride channel,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	BINDING:in chain A,BINDING:in chain B,CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Neurotransmitter-gated ion-channel ligand-binding,DOMAIN:Neurotransmitter-gated ion-channel transmembrane,MUTAGEN:M->T: Loss of picrotoxin resistance.,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q6DE37	glucoside xylosyltransferase 2 S homeolog(gxylt2.S)	Xenopus laevis			GO:0016266~O-glycan processing,	GO:0016020~membrane,	GO:0008194~UDP-glycosyltransferase activity,GO:0016757~glycosyltransferase activity,GO:0035252~UDP-xylosyltransferase activity,GO:0140563~UDP-D-xylose:beta-D-glucoside alpha-1,3-D-xylosyltransferase activity,	IPR002495:Glyco_trans_8,IPR029044:Nucleotide-diphossugar_trans,IPR051993:Glycosyltransferase_8,	xla00514:Other types of O-glycan biosynthesis,					KW-0472~Membrane,		KW-0732~Signal,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
Q14832	glutamate metabotropic receptor 3(GRM3)	Homo sapiens			GO:0007194~negative regulation of adenylate cyclase activity,GO:0007196~adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway,GO:0007216~G protein-coupled glutamate receptor signaling pathway,GO:0007268~chemical synaptic transmission,GO:0010467~gene expression,GO:0033554~cellular response to stress,GO:0051966~regulation of synaptic transmission, glutamatergic,GO:0099170~postsynaptic modulation of chemical synaptic transmission,	GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0030424~axon,GO:0042734~presynaptic membrane,GO:0043197~dendritic spine,GO:0045211~postsynaptic membrane,GO:0097449~astrocyte projection,GO:0098978~glutamatergic synapse,	GO:0001641~group II metabotropic glutamate receptor activity,GO:0004930~G protein-coupled receptor activity,GO:0005246~calcium channel regulator activity,GO:0008066~glutamate receptor activity,GO:0097110~scaffold protein binding,	IPR000162:GPCR_3_mtglu_rcpt,IPR000337:GPCR_3,IPR001234:GPCR_3_mGluR3,IPR001828:ANF_lig-bd_rcpt,IPR011500:GPCR_3_9-Cys_dom,IPR017978:GPCR_3_C,IPR017979:GPCR_3_CS,IPR028082:Peripla_BP_I,IPR038550:GPCR_3_9-Cys_sf,IPR050726:mGluR,	hsa04072:Phospholipase D signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04724:Glutamatergic synapse,hsa05030:Cocaine addiction,					KW-0472~Membrane,KW-1003~Cell membrane,		KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0297~G-protein coupled receptor,KW-0675~Receptor,KW-0807~Transducer,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:G-protein coupled receptors family 3 profile,DOMAIN:Receptor ligand binding region,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=7,
O08730	glycogenin 1(Gyg1)	Rattus norvegicus			GO:0005978~glycogen biosynthetic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0005536~D-glucose binding,GO:0008466~glycogenin glucosyltransferase activity,GO:0016757~glycosyltransferase activity,GO:0030145~manganese ion binding,GO:0042803~protein homodimerization activity,	IPR002495:Glyco_trans_8,IPR029044:Nucleotide-diphossugar_trans,IPR050587:GNT1/Glycosyltrans_8,	rno00500:Starch and sucrose metabolism,rno01100:Metabolic pathways,				KW-0320~Glycogen biosynthesis,				KW-0464~Manganese,KW-0479~Metal-binding,	KW-0808~Transferase,	KW-0007~Acetylation,KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:O-linked (Glc...) tyrosine,REGION:Disordered,REGION:Interaction with GYS1,SITE:Important for catalytic activity,
P17130	heterogeneous nuclear ribonucleoprotein A1 L homeolog(hnrnpa1.L)	Xenopus laevis				GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:1990904~ribonucleoprotein complex,	GO:0003723~RNA binding,	IPR000504:RRM_dom,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR034516:hnRNPA1/3_RRM2,IPR034845:hnRNPA1_RRM1,IPR035979:RBD_domain_sf,	xla03040:Spliceosome,			SM00360:RRM,		KW-0472~Membrane,KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0687~Ribonucleoprotein,KW-0694~RNA-binding,		COMPBIAS:Polar residues,DOMAIN:RRM,DOMAIN:RRM 1,DOMAIN:RRM 2,REGION:Disordered,REGION:Globular A domain,REGION:Globular B domain,REGION:Nuclear targeting sequence,TRANSMEM:Helical,
Q9DC33	high mobility group 20A(Hmg20a)	Mus musculus			GO:0000122~negative regulation of transcription by RNA polymerase II,GO:0006325~chromatin organization,GO:0010468~regulation of gene expression,GO:0033234~negative regulation of protein sumoylation,GO:0045665~negative regulation of neuron differentiation,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR009071:HMG_box_dom,IPR036910:HMG_box_dom_sf,IPR051965:ChromReg_NeuronalGeneExpr,				SM00398:HMG,	KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,		KW-0175~Coiled coil,		KW-0156~Chromatin regulator,KW-0238~DNA-binding,	KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DNA_BIND:HMG box,DOMAIN:HMG box,REGION:Disordered,
Q5FWS6	kazrin, periplakin interacting protein(Kazn)	Rattus norvegicus			GO:0031424~keratinization,	GO:0001533~cornified envelope,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0016607~nuclear speck,GO:0030057~desmosome,		IPR001660:SAM,IPR013761:SAM/pointed_sf,IPR037613:Kazrin_SAM_rpt_1,IPR037614:Kazrin,IPR037615:Kazrin_SAM_rpt_2,IPR037616:Kazrin_SAM_rpt_3,				SM00454:SAM,	KW-0417~Keratinization,	KW-0206~Cytoskeleton,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0965~Cell junction,		KW-0175~Coiled coil,KW-0677~Repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:SAM,DOMAIN:SAM 1,DOMAIN:SAM 2,DOMAIN:SAM 3,REGION:Disordered,
Q5S006	leucine-rich repeat kinase 2(Lrrk2)	Mus musculus		Function unknown,General function prediction only,	GO:0000165~MAPK cascade,GO:0001933~negative regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0006338~chromatin remodeling,GO:0006468~protein phosphorylation,GO:0006606~protein import into nucleus,GO:0006897~endocytosis,GO:0006914~autophagy,GO:0006979~response to oxidative stress,GO:0007005~mitochondrion organization,GO:0007029~endoplasmic reticulum organization,GO:0007030~Golgi organization,GO:0007040~lysosome organization,GO:0007165~signal transduction,GO:0007254~JNK cascade,GO:0007266~Rho protein signal transduction,GO:0007283~spermatogenesis,GO:0007528~neuromuscular junction development,GO:0008104~protein localization,GO:0008340~determination of adult lifespan,GO:0009267~cellular response to starvation,GO:0010468~regulation of gene expression,GO:0010506~regulation of autophagy,GO:0010508~positive regulation of autophagy,GO:0010738~regulation of protein kinase A signaling,GO:0010955~negative regulation of protein processing,GO:0010977~negative regulation of neuron projection development,GO:0014041~regulation of neuron maturation,GO:0016242~negative regulation of macroautophagy,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0019722~calcium-mediated signaling,GO:0021756~striatum development,GO:0021772~olfactory bulb development,GO:0022028~tangential migration from the subventricular zone to the olfactory bulb,GO:0030182~neuron differentiation,GO:0031344~regulation of cell projection organization,GO:0031398~positive regulation of protein ubiquitination,GO:0031647~regulation of protein stability,GO:0032091~negative regulation of protein binding,GO:0032092~positive regulation of protein binding,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032760~positive regulation of tumor necrosis factor production,GO:0034260~negative regulation of GTPase activity,GO:0034599~cellular response to oxidative stress,GO:0034614~cellular response to reactive oxygen species,GO:0035556~intracellular signal transduction,GO:0035564~regulation of kidney size,GO:0035640~exploration behavior,GO:0035641~locomotory exploration behavior,GO:0035751~regulation of lysosomal lumen pH,GO:0036465~synaptic vesicle recycling,GO:0040012~regulation of locomotion,GO:0042391~regulation of membrane potential,GO:0043068~positive regulation of programmed cell death,GO:0043406~positive regulation of MAP kinase activity,GO:0045746~negative regulation of Notch signaling pathway,GO:0045860~positive regulation of protein kinase activity,GO:0046039~GTP metabolic process,GO:0046777~protein autophosphorylation,GO:0048312~intracellular distribution of mitochondria,GO:0048812~neuron projection morphogenesis,GO:0051646~mitochondrion localization,GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process,GO:0051900~regulation of mitochondrial depolarization,GO:0051966~regulation of synaptic transmission, glutamatergic,GO:0060079~excitatory postsynaptic potential,GO:0060159~regulation of dopamine receptor signaling pathway,GO:0060161~positive regulation of dopamine receptor signaling pathway,GO:0060628~regulation of ER to Golgi vesicle-mediated transport,GO:0060828~regulation of canonical Wnt signaling pathway,GO:0061001~regulation of dendritic spine morphogenesis,GO:0070973~protein localization to endoplasmic reticulum exit site,GO:0071287~cellular response to manganese ion,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:0090394~negative regulation of excitatory postsynaptic potential,GO:0140058~neuron projection arborization,GO:0141161~regulation of cAMP/PKA signal transduction,GO:1900242~regulation of synaptic vesicle endocytosis,GO:1900244~positive regulation of synaptic vesicle endocytosis,GO:1902236~negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,GO:1902499~positive regulation of protein autoubiquitination,GO:1902692~regulation of neuroblast proliferation,GO:1902803~regulation of synaptic vesicle transport,GO:1902902~negative regulation of autophagosome assembly,GO:1903125~negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation,GO:1903215~negative regulation of protein targeting to mitochondrion,GO:1903351~cellular response to dopamine,GO:1903980~positive regulation of microglial cell activation,GO:1904887~Wnt signalosome assembly,GO:1905279~regulation of retrograde transport, endosome to Golgi,GO:1905289~regulation of CAMKK-AMPK signaling cascade,GO:2000172~regulation of branching morphogenesis of a nerve,GO:2000300~regulation of synaptic vesicle exocytosis,GO:2000377~regulation of reactive oxygen species metabolic process,	GO:0000139~Golgi membrane,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0005764~lysosome,GO:0005768~endosome,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005798~Golgi-associated vesicle,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005902~microvillus,GO:0008021~synaptic vesicle,GO:0016020~membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0030426~growth cone,GO:0030672~synaptic vesicle membrane,GO:0031410~cytoplasmic vesicle,GO:0031966~mitochondrial membrane,GO:0032473~cytoplasmic side of mitochondrial outer membrane,GO:0032839~dendrite cytoplasm,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043195~terminal bouton,GO:0043204~perikaryon,GO:0043231~intracellular membrane-bounded organelle,GO:0044753~amphisome,GO:0044754~autolysosome,GO:0045121~membrane raft,GO:0045202~synapse,GO:0045335~phagocytic vesicle,GO:0070971~endoplasmic reticulum exit site,GO:0097487~multivesicular body, internal vesicle,GO:0098794~postsynapse,GO:0098978~glutamatergic synapse,GO:0099400~caveola neck,GO:0099523~presynaptic cytosol,GO:1990904~ribonucleoprotein complex,GO:1990909~Wnt signalosome,	GO:0000149~SNARE binding,GO:0000287~magnesium ion binding,GO:0003779~actin binding,GO:0003924~GTPase activity,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004676~3-phosphoinositide-dependent protein kinase activity,GO:0004677~DNA-dependent protein kinase activity,GO:0004679~AMP-activated protein kinase activity,GO:0004694~eukaryotic translation initiation factor 2alpha kinase activity,GO:0004706~JUN kinase kinase kinase activity,GO:0004709~MAP kinase kinase kinase activity,GO:0004711~ribosomal protein S6 kinase activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0015631~tubulin binding,GO:0016301~kinase activity,GO:0017075~syntaxin-1 binding,GO:0030159~signaling receptor complex adaptor activity,GO:0030276~clathrin binding,GO:0031267~small GTPase binding,GO:0034211~GTP-dependent protein kinase activity,GO:0035175~histone H3S10 kinase activity,GO:0035402~histone H3T11 kinase activity,GO:0035403~histone H3T6 kinase activity,GO:0035979~histone H2AXS139 kinase activity,GO:0036479~peroxidase inhibitor activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0044022~histone H3S28 kinase activity,GO:0044023~histone H4S1 kinase activity,GO:0044024~histone H2AS1 kinase activity,GO:0044025~histone H2BS14 kinase activity,GO:0044325~transmembrane transporter binding,GO:0044877~protein-containing complex binding,GO:0051018~protein kinase A binding,GO:0072354~histone H3T3 kinase activity,GO:0072371~histone H2AS121 kinase activity,GO:0072518~Rho-dependent protein serine/threonine kinase activity,GO:0106310~protein serine kinase activity,GO:0140823~histone H2BS36 kinase activity,GO:0140855~histone H3S57 kinase activity,GO:0140857~histone H3T45 kinase activity,GO:1904713~beta-catenin destruction complex binding,GO:1990244~histone H2AT120 kinase activity,GO:1990606~membrane scission GTPase motor activity,	IPR000719:Prot_kinase_dom,IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR005225:Small_GTP-bd_dom,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR011989:ARM-like,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR016024:ARM-type_fold,IPR017441:Protein_kinase_ATP_BS,IPR020859:ROC_dom,IPR027417:P-loop_NTPase,IPR032171:COR,IPR032675:LRR_dom_sf,IPR036322:WD40_repeat_dom_sf,IPR036770:Ankyrin_rpt-contain_sf,IPR051420:Ser_Thr_Kinases_DiverseReg,IPR053215:TKL_Ser/Thr_kinase,	mmu05012:Parkinson disease,mmu05022:Pathways of neurodegeneration - multiple diseases,			SM00175:RAB,SM00220:S_TKc,SM00364:LRR_BAC,SM00369:LRR_TYP,	KW-0072~Autophagy,KW-0221~Differentiation,	KW-0206~Cytoskeleton,KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0458~Lysosome,KW-0472~Membrane,KW-0496~Mitochondrion,KW-0770~Synapse,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0967~Endosome,KW-0968~Cytoplasmic vesicle,KW-1000~Mitochondrion outer membrane,		KW-0175~Coiled coil,KW-0433~Leucine-rich repeat,KW-0677~Repeat,KW-0812~Transmembrane,KW-0853~WD repeat,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0342~GTP-binding,KW-0547~Nucleotide-binding,	KW-0343~GTPase activation,KW-0378~Hydrolase,KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,	ACT_SITE:Proton acceptor,COMPBIAS:Polar residues,DOMAIN:COR,DOMAIN:Protein kinase,DOMAIN:Roc,MUTAGEN:A->T: Does not affect kinase activity and decreases sensitivity towards small molecule kinase inhibitors.,MUTAGEN:G->S: Increases kinase activity. Causes loss of dopaminergic neurons in the substantia nigra of 20-month old mice due to increased phosphorylation of APP. Reduces primary ciliogenesis.,MUTAGEN:R->C: Impaired ability to recruit SEC61A and SEC31A to endoplasmic reticulum exit sites. Impaired ability to regulate ER to Golgi vesicle-mediated transport.,MUTAGEN:R->G: Increases kinase activity. Reduces primary ciliogenesis. Causes fragmentation of the trans-Golgi network.,REGION:Disordered,REPEAT:LRR 1,REPEAT:LRR 10,REPEAT:LRR 11,REPEAT:LRR 12,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,REPEAT:WD 6,REPEAT:WD 7,TRANSMEM:Helical,
Q6Z7K5	metal tolerance protein 3-like(LOC4330894)	Oryza sativa Japonica Group			GO:0006812~monoatomic cation transport,GO:0055085~transmembrane transport,	GO:0005774~vacuolar membrane,GO:0016020~membrane,	GO:0005384~manganese ion transmembrane transporter activity,GO:0008324~monoatomic cation transmembrane transporter activity,	IPR002524:Cation_efflux,IPR027469:Cation_efflux_TMD_sf,IPR027470:Cation_efflux_CTD,IPR036837:Cation_efflux_CTD_sf,IPR050291:CDF_Transporter,					KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,KW-0926~Vacuole,		KW-0812~Transmembrane,KW-1133~Transmembrane helix,				COMPBIAS:Basic and acidic residues,DOMAIN:Cation efflux protein cytoplasmic,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Vacuolar,TRANSMEM:Helical,
Q99LB6	methionine adenosyltransferase 2 non-catalytic beta subunit methionine(Mat2b)	Mus musculus			GO:0006556~S-adenosylmethionine biosynthetic process,GO:0006730~one-carbon metabolic process,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0048269~methionine adenosyltransferase complex,	GO:0019899~enzyme binding,GO:0048270~methionine adenosyltransferase regulator activity,	IPR005913:dTDP_dehydrorham_reduct,IPR029903:RmlD-like-bd,IPR036291:NAD(P)-bd_dom_sf,	mmu00270:Cysteine and methionine metabolism,mmu00670:One carbon pool by folate,mmu01100:Metabolic pathways,mmu01230:Biosynthesis of amino acids,mmu01240:Biosynthesis of cofactors,				KW-0554~One-carbon metabolism,				KW-0521~NADP,		KW-0597~Phosphoprotein,	DOMAIN:RmlD-like substrate binding,REGION:Required for interaction with MAT2A,
Q9CQ19	myosin, light polypeptide 9, regulatory(Myl9)	Mus musculus		Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only,	GO:0030239~myofibril assembly,	GO:0001725~stress fiber,GO:0005737~cytoplasm,GO:0005938~cell cortex,GO:0016460~myosin II complex,GO:0030016~myofibril,GO:0030018~Z disc,	GO:0005509~calcium ion binding,GO:0032036~myosin heavy chain binding,	IPR002048:EF_hand_dom,IPR011992:EF-hand-dom_pair,IPR018247:EF_Hand_1_Ca_BS,IPR050403:Myosin_RLC,	mmu04022:cGMP-PKG signaling pathway,mmu04024:cAMP signaling pathway,mmu04270:Vascular smooth muscle contraction,mmu04360:Axon guidance,mmu04510:Focal adhesion,mmu04520:Adherens junction,mmu04530:Tight junction,mmu04670:Leukocyte transendothelial migration,mmu04810:Regulation of actin cytoskeleton,mmu04814:Motor proteins,mmu04820:Cytoskeleton in muscle cells,mmu04921:Oxytocin signaling pathway,mmu05132:Salmonella infection,			SM00054:EFh,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,		KW-0677~Repeat,	KW-0106~Calcium,KW-0479~Metal-binding,	KW-0505~Motor protein,KW-0514~Muscle protein,KW-0518~Myosin,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:EF-hand,DOMAIN:EF-hand 1,DOMAIN:EF-hand 2,DOMAIN:EF-hand 3,MUTAGEN:S->D: Prevents aberrant myotube formation in PIEZO1-deficient myoblast; when associated with D-19.,MUTAGEN:T->D: Prevents aberrant myotube formation in PIEZO1-deficient myoblast; when associated with D-20.,REGION:Disordered,
P0CI65	nephronophthisis 3(nphp3)	Danio rerio			GO:0001822~kidney development,GO:0003146~heart jogging,GO:0007368~determination of left/right symmetry,GO:0007601~visual perception,GO:0016055~Wnt signaling pathway,GO:0048793~pronephros development,GO:0060026~convergent extension,GO:0060271~cilium assembly,GO:0060972~left/right pattern formation,GO:0070121~Kupffer's vesicle development,	GO:0005929~cilium,GO:0042995~cell projection,GO:0097543~ciliary inversin compartment,GO:0097546~ciliary base,		IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,IPR027417:P-loop_NTPase,IPR051787:Effector/Ciliary-Dev_Assoc,				SM00028:TPR,	KW-0879~Wnt signaling pathway,	KW-0966~Cell projection,KW-0969~Cilium,		KW-0175~Coiled coil,KW-0677~Repeat,KW-0802~TPR repeat,				COMPBIAS:Polar residues,REGION:Disordered,REPEAT:TPR 1,REPEAT:TPR 10,REPEAT:TPR 2,REPEAT:TPR 3,REPEAT:TPR 4,REPEAT:TPR 5,REPEAT:TPR 6,REPEAT:TPR 7,REPEAT:TPR 8,REPEAT:TPR 9,
Q99743	neuronal PAS domain protein 2(NPAS2)	Homo sapiens			GO:0006357~regulation of transcription by RNA polymerase II,GO:0006974~DNA damage response,GO:0007417~central nervous system development,GO:0009410~response to xenobiotic stimulus,GO:0032922~circadian regulation of gene expression,GO:0045739~positive regulation of DNA repair,GO:0045893~positive regulation of DNA-templated transcription,GO:0051775~response to redox state,GO:2000987~positive regulation of behavioral fear response,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription regulator complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:1990513~CLOCK-BMAL transcription complex,	GO:0000978~RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000981~DNA-binding transcription factor activity, RNA polymerase II-specific,GO:0003677~DNA binding,GO:0003700~DNA-binding transcription factor activity,GO:0005515~protein binding,GO:0046872~metal ion binding,GO:0046983~protein dimerization activity,GO:0051879~Hsp90 protein binding,GO:0070888~E-box binding,GO:1990837~sequence-specific double-stranded DNA binding,	IPR000014:PAS,IPR001067:Nuc_translocat,IPR001610:PAC,IPR011598:bHLH_dom,IPR013767:PAS_fold,IPR035965:PAS-like_dom_sf,IPR036638:HLH_DNA-bd_sf,IPR047230:CLOCK-like,	hsa04710:Circadian rhythm,			SM00086:PAC,SM00091:PAS,SM00353:HLH,	KW-0090~Biological rhythms,KW-0227~DNA damage,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0539~Nucleus,		KW-0677~Repeat,	KW-0349~Heme,KW-0408~Iron,KW-0479~Metal-binding,	KW-0010~Activator,KW-0238~DNA-binding,		BINDING:axial binding residue,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:BHLH,DOMAIN:PAC,DOMAIN:PAS,DOMAIN:PAS 1,DOMAIN:PAS 2,DOMAIN:bHLH,REGION:Disordered,REGION:Sufficient for heterodimer formation with BMAL1, E-box binding and for the effect of NADPH,
Q9CQM0	nicolin 1(Nicn1)	Mus musculus			GO:0008150~biological_process,	GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0005874~microtubule,	GO:0003674~molecular_function,	IPR040235:Nicolin-1,						KW-0493~Microtubule,KW-0539~Nucleus,
Q6V0K7	oncoprotein induced transcript 3(Oit3)	Rattus norvegicus			GO:0003014~renal system process,	GO:0005615~extracellular space,GO:0005635~nuclear envelope,GO:0009986~cell surface,	GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR000742:EGF-like_dom,IPR001507:ZP_dom,IPR001881:EGF-like_Ca-bd_dom,IPR042235:ZP-C,IPR048290:ZP_chr,				SM00179:EGF_CA,SM00181:EGF,SM00241:ZP,		KW-0539~Nucleus,		KW-0245~EGF-like domain,KW-0732~Signal,	KW-0106~Calcium,		KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:EGF-like; calcium-binding,DOMAIN:ZP,REGION:Disordered,
Q7ZU45	outer dynein arm docking complex subunit 4(odad4)	Danio rerio			GO:0003341~cilium movement,GO:0032474~otolith morphogenesis,GO:0036158~outer dynein arm assembly,GO:0060271~cilium assembly,GO:0061371~determination of heart left/right asymmetry,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0042995~cell projection,		IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,IPR040111:ODAD4,				SM00028:TPR,		KW-0206~Cytoskeleton,KW-0963~Cytoplasm,KW-0966~Cell projection,		KW-0677~Repeat,KW-0802~TPR repeat,				REGION:Disordered,REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,REPEAT:TPR 4,REPEAT:TPR 5,REPEAT:TPR 6,REPEAT:TPR 7,
Q1L9A2	outer mitochondrial membrane lipid metabolism regulator OPA3(opa3)	Danio rerio			GO:0007626~locomotory behavior,GO:0019216~regulation of lipid metabolic process,GO:0031413~regulation of buoyancy,GO:0050881~musculoskeletal movement,	GO:0005739~mitochondrion,		IPR010754:OPA3-like,						KW-0496~Mitochondrion,		KW-0175~Coiled coil,
P50542	peroxisomal biogenesis factor 5(PEX5)	Homo sapiens		General function prediction only,	GO:0000038~very long-chain fatty acid metabolic process,GO:0000425~pexophagy,GO:0001764~neuron migration,GO:0006625~protein targeting to peroxisome,GO:0006635~fatty acid beta-oxidation,GO:0007006~mitochondrial membrane organization,GO:0007029~endoplasmic reticulum organization,GO:0015031~protein transport,GO:0016558~protein import into peroxisome matrix,GO:0016560~protein import into peroxisome matrix, docking,GO:0016561~protein import into peroxisome matrix, translocation,GO:0016562~protein import into peroxisome matrix, receptor recycling,GO:0021795~cerebral cortex cell migration,GO:0021895~cerebral cortex neuron differentiation,GO:0031333~negative regulation of protein-containing complex assembly,GO:0034614~cellular response to reactive oxygen species,GO:0040018~positive regulation of multicellular organism growth,GO:0044721~protein import into peroxisome matrix, substrate release,GO:0045046~protein import into peroxisome membrane,GO:0048468~cell development,GO:0050905~neuromuscular process,GO:0051262~protein tetramerization,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0005782~peroxisomal matrix,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0016020~membrane,GO:0032991~protein-containing complex,	GO:0000268~peroxisome targeting sequence binding,GO:0005052~peroxisome matrix targeting signal-1 binding,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0031267~small GTPase binding,GO:0033328~peroxisome membrane targeting sequence binding,GO:0140597~protein carrier chaperone,	IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,IPR024111:PEX5/PEX5L,	hsa04146:Peroxisome,	202370~Peroxisome biogenesis disorder 2B,214110~Peroxisome biogenesis disorder 2A (Zellweger),616716~Rhizomelic chondrodysplasia punctata, type 5,		SM00028:TPR,	KW-0653~Protein transport,KW-0811~Translocation,KW-0813~Transport,	KW-0576~Peroxisome,KW-0963~Cytoplasm,	KW-0225~Disease variant,KW-0685~Rhizomelic chondrodysplasia punctata,KW-0861~Zellweger syndrome,KW-0958~Peroxisome biogenesis disorder,	KW-0677~Repeat,KW-0802~TPR repeat,		KW-0675~Receptor,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-0882~Thioester bond,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl cysteine thioester (Cys-Gly) (interchain with G-Cter in ubiquitin),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),MOTIF:LVxEF motif,MOTIF:WxxxF/Y motif 1,MOTIF:WxxxF/Y motif 2,MOTIF:WxxxF/Y motif 3,MOTIF:WxxxF/Y motif 4,MOTIF:WxxxF/Y motif 5,MOTIF:WxxxF/Y motif 6,MOTIF:WxxxF/Y motif 7,MUTAGEN:C->A: Promotes accumulation at the peroxisomal membrane because of impaired export into the cytosol. Does not affect monoubiquitination by TRIM37.,MUTAGEN:C->K: Does not affect ability to mediate peroxisomal import of proteins.,MUTAGEN:C->S,R: Promotes accumulation at the peroxisomal membrane because of impaired export into the cytosol.,MUTAGEN:F->A: Strongly reduced interaction with PEX14.,MUTAGEN:K->A: Abolished monoubiquitination by TRIM37, leading to decreased stability.,MUTAGEN:K->A: Does not affect monoubiquitination by TRIM37.,MUTAGEN:K->R: Abolished interaction with SQSTM1, leading to decreased pexophagy in response to reactive oxygen species (ROS).,MUTAGEN:K->R: Does not affect PEX5 recycling.,MUTAGEN:LVAEF->AAAAA: Abolished interaction with PEX14.,MUTAGEN:S->A: Abolished phosphorylation by ATM, leading to impaired monoubiquitination at K-209.,MUTAGEN:S->E: Mimics phosphorylation, leading to increased pexophagy in response to reactive oxygen species (ROS).,MUTAGEN:W->A: Decreased interaction with PEX14.,MUTAGEN:W->A: Strongly reduced interaction with PEX14.,REGION:Amphipathic helix 1 (AH1),REGION:Amphipathic helix 2 (AH2),REGION:Amphipathic helix 3 (AH3),REGION:Amphipathic helix 4 (AH4),REGION:Disordered,REPEAT:TPR,REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,REPEAT:TPR 4,REPEAT:TPR 5,REPEAT:TPR 6,REPEAT:TPR 7,SITE:Sensor of redox state,
O54853	potassium voltage-gated channel subfamily H member 6(Kcnh6)	Rattus norvegicus			GO:0006813~potassium ion transport,GO:0060307~regulation of ventricular cardiac muscle cell membrane repolarization,GO:0071805~potassium ion transmembrane transport,GO:0086011~membrane repolarization during action potential,GO:0086013~membrane repolarization during cardiac muscle cell action potential,GO:0086091~regulation of heart rate by cardiac conduction,	GO:0005886~plasma membrane,GO:0034702~monoatomic ion channel complex,	GO:0005242~inward rectifier potassium channel activity,GO:0005249~voltage-gated potassium channel activity,GO:0005267~potassium channel activity,GO:0044877~protein-containing complex binding,	IPR000014:PAS,IPR000595:cNMP-bd_dom,IPR003938:K_chnl_volt-dep_EAG/ELK/ERG,IPR003967:K_chnl_volt-dep_ERG,IPR005821:Ion_trans_dom,IPR014710:RmlC-like_jellyroll,IPR018490:cNMP-bd_dom_sf,IPR035965:PAS-like_dom_sf,IPR050818:KCNH_channel,				SM00100:cNMP,	KW-0406~Ion transport,KW-0633~Potassium transport,KW-0813~Transport,	KW-0472~Membrane,KW-1003~Cell membrane,		KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0630~Potassium,	KW-0407~Ion channel,KW-0631~Potassium channel,KW-0851~Voltage-gated channel,		DOMAIN:Cyclic nucleotide-binding,DOMAIN:PAC,DOMAIN:PAS,INTRAMEM:Pore-forming; Name=Segment H5,MOTIF:Selectivity filter,MUTAGEN:G->S: Dominant negative mutant; abolishes ERG current.,REGION:Disordered,REGION:cNMP-binding domain,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,TRANSMEM:Helical; Name=Segment S1,TRANSMEM:Helical; Name=Segment S2,TRANSMEM:Helical; Name=Segment S3,TRANSMEM:Helical; Name=Segment S5,TRANSMEM:Helical; Name=Segment S6,TRANSMEM:Helical; Voltage-sensor; Name=Segment S4,
Q86UA1	pre-mRNA processing factor 39(PRPF39)	Homo sapiens		RNA processing and modification,	GO:0000395~mRNA 5'-splice site recognition,GO:0006396~RNA processing,	GO:0000243~commitment complex,GO:0005634~nucleus,GO:0005685~U1 snRNP,GO:0071004~U2-type prespliceosome,	GO:0005515~protein binding,GO:0030627~pre-mRNA 5'-splice site binding,	IPR003107:HAT,IPR008847:Suf,IPR011990:TPR-like_helical_dom_sf,				SM00386:HAT,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,		KW-0677~Repeat,			KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Suppressor of forked,REGION:Disordered,REPEAT:HAT 1,REPEAT:HAT 2,REPEAT:HAT 3,REPEAT:HAT 4,REPEAT:HAT 5,REPEAT:HAT 6,REPEAT:HAT 7,
Q5XIU9	progesterone receptor membrane component 2(Pgrmc2)	Rattus norvegicus			GO:0015886~heme transport,GO:0060612~adipose tissue development,	GO:0005576~extracellular region,GO:0005635~nuclear envelope,GO:0005783~endoplasmic reticulum,GO:0012505~endomembrane system,GO:0016020~membrane,GO:0045202~synapse,GO:0098978~glutamatergic synapse,	GO:0005496~steroid binding,GO:0015232~heme transmembrane transporter activity,GO:0020037~heme binding,	IPR001199:Cyt_B5-like_heme/steroid-bd,IPR036400:Cyt_B5-like_heme/steroid_sf,IPR050577:Cytochrome_b5-MAPR/VMP1_fams,	rno04080:Neuroactive ligand-receptor interaction,			SM01117:Cyt-b5,		KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0539~Nucleus,KW-0964~Secreted,		KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0446~Lipid-binding,KW-0754~Steroid-binding,	KW-0675~Receptor,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-0654~Proteoglycan,	CARBOHYD:O-linked (Xyl...) (chondroitin sulfate) serine,DOMAIN:Cytochrome b5 heme-binding,REGION:Disordered,TRANSMEM:Helical,
A0A3M6TIF0	protein mab-21-like(LOC113677374)	Pocillopora damicornis			GO:0045087~innate immune response,		GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0046872~metal ion binding,GO:0061501~2',3'-cyclic GMP-AMP synthase activity,	IPR024810:MAB21L/cGLR,IPR046906:Mab-21_HhH/H2TH-like,				SM01265:Mab-21,	KW-0391~Immunity,KW-0399~Innate immunity,				KW-0067~ATP-binding,KW-0342~GTP-binding,KW-0460~Magnesium,KW-0464~Manganese,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0548~Nucleotidyltransferase,KW-0808~Transferase,		MUTAGEN:D->N: Abolished nucleotidyltransferase activity.,
P58389	protein phosphatase 2 protein activator(Ptpa)	Mus musculus			GO:0006357~regulation of transcription by RNA polymerase II,GO:0007052~mitotic spindle organization,GO:0043065~positive regulation of apoptotic process,	GO:0000159~protein phosphatase type 2A complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0034704~calcium channel complex,GO:1904949~ATPase complex,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0004721~phosphoprotein phosphatase activity,GO:0005102~signaling receptor binding,GO:0005524~ATP binding,GO:0008160~protein tyrosine phosphatase activator activity,GO:0019211~phosphatase activator activity,GO:0019888~protein phosphatase regulator activity,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0051721~protein phosphatase 2A binding,GO:0140839~RNA polymerase II CTD heptapeptide repeat P3 isomerase activity,GO:0140840~RNA polymerase II CTD heptapeptide repeat P6 isomerase activity,	IPR004327:Phstyr_phstse_ac,IPR037218:PTPA_sf,IPR043170:PTPA_C_lid,	mmu04931:Insulin resistance,mmu05415:Diabetic cardiomyopathy,		PIRSF016325:Phstyr_phstse_ac,			KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0067~ATP-binding,KW-0460~Magnesium,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0413~Isomerase,KW-0697~Rotamase,	KW-0007~Acetylation,	REGION:Disordered,
Q641Z2	protein tyrosine phosphatase, non-receptor type 9(Ptpn9)	Rattus norvegicus			GO:0006338~chromatin remodeling,GO:0007165~signal transduction,GO:0010977~negative regulation of neuron projection development,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:1903078~positive regulation of protein localization to plasma membrane,	GO:0005737~cytoplasm,GO:0044306~neuron projection terminus,	GO:0004725~protein tyrosine phosphatase activity,GO:0004726~non-membrane spanning protein tyrosine phosphatase activity,GO:0030946~protein tyrosine phosphatase activity, metal-dependent,GO:0140793~histone H2AXY142 phosphatase activity,	IPR000242:PTP_cat,IPR000387:Tyr_Pase_dom,IPR001251:CRAL-TRIO_dom,IPR003595:Tyr_Pase_cat,IPR016130:Tyr_Pase_AS,IPR029021:Prot-tyrosine_phosphatase-like,IPR036273:CRAL/TRIO_N_dom_sf,IPR036865:CRAL-TRIO_dom_sf,IPR050348:Protein-Tyr_Phosphatase,				SM00194:PTPc,SM00404:PTPc_motif,SM00516:SEC14,		KW-0963~Cytoplasm,				KW-0378~Hydrolase,KW-0675~Receptor,KW-0904~Protein phosphatase,	KW-0007~Acetylation,	ACT_SITE:Phosphocysteine intermediate,DOMAIN:CRAL-TRIO,DOMAIN:Tyrosine specific protein phosphatases,DOMAIN:Tyrosine-protein phosphatase,REGION:Disordered,
P07949	ret proto-oncogene(RET)	Homo sapiens			GO:0000165~MAPK cascade,GO:0001657~ureteric bud development,GO:0001755~neural crest cell migration,GO:0001838~embryonic epithelial tube formation,GO:0006338~chromatin remodeling,GO:0006468~protein phosphorylation,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007158~neuron cell-cell adhesion,GO:0007165~signal transduction,GO:0007169~cell surface receptor protein tyrosine kinase signaling pathway,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007275~multicellular organism development,GO:0007411~axon guidance,GO:0007497~posterior midgut development,GO:0008286~insulin receptor signaling pathway,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0009410~response to xenobiotic stimulus,GO:0010628~positive regulation of gene expression,GO:0010976~positive regulation of neuron projection development,GO:0014042~positive regulation of neuron maturation,GO:0030155~regulation of cell adhesion,GO:0030335~positive regulation of cell migration,GO:0031547~brain-derived neurotrophic factor receptor signaling pathway,GO:0033141~positive regulation of peptidyl-serine phosphorylation of STAT protein,GO:0033619~membrane protein proteolysis,GO:0033630~positive regulation of cell adhesion mediated by integrin,GO:0035790~platelet-derived growth factor receptor-alpha signaling pathway,GO:0035791~platelet-derived growth factor receptor-beta signaling pathway,GO:0035799~ureter maturation,GO:0035860~glial cell-derived neurotrophic factor receptor signaling pathway,GO:0036323~vascular endothelial growth factor receptor-1 signaling pathway,GO:0038063~collagen-activated tyrosine kinase receptor signaling pathway,GO:0038084~vascular endothelial growth factor signaling pathway,GO:0038109~Kit signaling pathway,GO:0038145~macrophage colony-stimulating factor signaling pathway,GO:0042551~neuron maturation,GO:0043410~positive regulation of MAPK cascade,GO:0045793~positive regulation of cell size,GO:0045893~positive regulation of DNA-templated transcription,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0048012~hepatocyte growth factor receptor signaling pathway,GO:0048013~ephrin receptor signaling pathway,GO:0048265~response to pain,GO:0048484~enteric nervous system development,GO:0050770~regulation of axonogenesis,GO:0051897~positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,GO:0060041~retina development in camera-type eye,GO:0060384~innervation,GO:0061146~Peyer's patch morphogenesis,GO:0071300~cellular response to retinoic acid,GO:0072300~positive regulation of metanephric glomerulus development,GO:0097021~lymphocyte migration into lymphoid organs,GO:0160144~GDF15-GFRAL signaling pathway,GO:2001056~positive regulation of cysteine-type endopeptidase activity,GO:2001241~positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005769~early endosome,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0016020~membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0043235~receptor complex,GO:0098797~plasma membrane protein complex,	GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005004~GPI-linked ephrin receptor activity,GO:0005005~transmembrane-ephrin receptor activity,GO:0005006~epidermal growth factor receptor activity,GO:0005007~fibroblast growth factor receptor activity,GO:0005008~hepatocyte growth factor receptor activity,GO:0005009~insulin receptor activity,GO:0005010~insulin-like growth factor receptor activity,GO:0005011~macrophage colony-stimulating factor receptor activity,GO:0005018~platelet-derived growth factor alpha-receptor activity,GO:0005019~platelet-derived growth factor beta-receptor activity,GO:0005020~stem cell factor receptor activity,GO:0005021~vascular endothelial growth factor receptor activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008288~boss receptor activity,GO:0016301~kinase activity,GO:0035401~histone H3Y41 kinase activity,GO:0036332~placental growth factor receptor activity,GO:0038023~signaling receptor activity,GO:0038062~protein tyrosine kinase collagen receptor activity,GO:0060175~brain-derived neurotrophic factor receptor activity,GO:0140801~histone H2AXY142 kinase activity,	IPR000719:Prot_kinase_dom,IPR001245:Ser-Thr/Tyr_kinase_cat_dom,IPR002126:Cadherin-like_dom,IPR008266:Tyr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR015919:Cadherin-like_sf,IPR016249:Tyr_kinase_Ret_rcpt,IPR017441:Protein_kinase_ATP_BS,IPR020635:Tyr_kinase_cat_dom,IPR040667:Ret_CLD3,IPR041163:Ret_CLD1,IPR041317:RET_CLD4,IPR050122:RTK,	hsa04010:MAPK signaling pathway,hsa04020:Calcium signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa05200:Pathways in cancer,hsa05216:Thyroid cancer,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,	142623~Hirschsprung disease, protection against,142623~Hirschsprung disease, susceptibility to, 1,155240~Medullary thyroid carcinoma,162300~Multiple endocrine neoplasia IIB,171300~Pheochromocytoma,171400~Multiple endocrine neoplasia IIA,	PIRSF000631:TyrPK_receptor_Ret,	SM00219:TyrKc,	KW-0130~Cell adhesion,	KW-0472~Membrane,KW-0967~Endosome,KW-1003~Cell membrane,	KW-0225~Disease variant,KW-0367~Hirschsprung disease,KW-0656~Proto-oncogene,	KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0106~Calcium,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0675~Receptor,KW-0808~Transferase,KW-0829~Tyrosine-protein kinase,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:O-linked (GlcNAc) serine,DOMAIN:Cadherin,DOMAIN:Protein kinase,DOMAIN:Ret cadherin like,MUTAGEN:D->N: Impaired cleavage by caspase-3 and loss of induced cell death.,MUTAGEN:E->A: Enhanced protein autophosphorylation due to enhanced substrate presentation in trans.,MUTAGEN:I->A: Enhanced protein autophosphorylation due to enhanced substrate presentation in trans.,MUTAGEN:K->R,M: Loss of kinase activity. No effect on interaction with and dissociation from CBLC and CD2AP.,MUTAGEN:Missing: Loss of induced cell death, but increased cell aggregation.,MUTAGEN:R->A: Enhanced protein autophosphorylation due to enhanced substrate presentation in trans.,MUTAGEN:W->A: Defects in maturation and processing.,MUTAGEN:Y->A: Defects in maturation and processing.,MUTAGEN:Y->F: Abolishes GFRAL-mediated MAPK1/MAPK2 phosphorylation.,MUTAGEN:Y->S: Defects in maturation and processing.,REGION:Cadherin-like region 1 (CLD1),REGION:Cadherin-like region 3 (CLD3),REGION:Cadherin-like region 4 (CLD4),REGION:Disordered,SITE:Breakpoint for translocation to form PCM1-RET; RET-CCDC6; RET-GOLGA5; RET-TRIM24 and RET-TRIM33 oncogenes,SITE:Breakpoint for translocation to form the TRIM27/RET oncogene,SITE:Cleavage; by caspase-3,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
P0CT39	retrotransposable element/transposon Tf2-type(Tf2-12)	Schizosaccharomyces pombe			GO:0006310~DNA recombination,GO:0006508~proteolysis,GO:0015074~DNA integration,	GO:0005575~cellular_component,GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0003964~RNA-directed DNA polymerase activity,GO:0004190~aspartic-type endopeptidase activity,GO:0004519~endonuclease activity,GO:0046872~metal ion binding,	IPR000477:RT_dom,IPR001584:Integrase_cat-core,IPR001969:Aspartic_peptidase_AS,IPR012337:RNaseH-like_sf,IPR021109:Peptidase_aspartic_dom_sf,IPR024648:Pept_A2E_retrotransp,IPR036397:RNaseH_sf,IPR041577:RT_RNaseH_2,IPR041588:Integrase_H2C2,IPR043128:Rev_trsase/Diguanyl_cyclase,IPR043502:DNA/RNA_pol_sf,IPR050951:Retrovirus_Pol_polyprotein,					KW-0229~DNA integration,KW-0233~DNA recombination,				KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0064~Aspartyl protease,KW-0238~DNA-binding,KW-0239~DNA-directed DNA polymerase,KW-0255~Endonuclease,KW-0378~Hydrolase,KW-0511~Multifunctional enzyme,KW-0540~Nuclease,KW-0548~Nucleotidyltransferase,KW-0645~Protease,KW-0694~RNA-binding,KW-0695~RNA-directed DNA polymerase,KW-0808~Transferase,		ACT_SITE:For protease activity,COMPBIAS:Polar residues,DOMAIN:Integrase catalytic,DOMAIN:Peptidase A2,DOMAIN:Reverse transcriptase,REGION:Disordered,
P0CT39	retrotransposable element/transposon Tf2-type(Tf2-3)	Schizosaccharomyces pombe			GO:0006310~DNA recombination,GO:0006508~proteolysis,GO:0015074~DNA integration,	GO:0005575~cellular_component,GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0003964~RNA-directed DNA polymerase activity,GO:0004190~aspartic-type endopeptidase activity,GO:0004519~endonuclease activity,GO:0046872~metal ion binding,	IPR000477:RT_dom,IPR001584:Integrase_cat-core,IPR001969:Aspartic_peptidase_AS,IPR012337:RNaseH-like_sf,IPR021109:Peptidase_aspartic_dom_sf,IPR024648:Pept_A2E_retrotransp,IPR036397:RNaseH_sf,IPR041577:RT_RNaseH_2,IPR041588:Integrase_H2C2,IPR043128:Rev_trsase/Diguanyl_cyclase,IPR043502:DNA/RNA_pol_sf,IPR050951:Retrovirus_Pol_polyprotein,					KW-0229~DNA integration,KW-0233~DNA recombination,				KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0064~Aspartyl protease,KW-0238~DNA-binding,KW-0239~DNA-directed DNA polymerase,KW-0255~Endonuclease,KW-0378~Hydrolase,KW-0511~Multifunctional enzyme,KW-0540~Nuclease,KW-0548~Nucleotidyltransferase,KW-0645~Protease,KW-0694~RNA-binding,KW-0695~RNA-directed DNA polymerase,KW-0808~Transferase,		ACT_SITE:For protease activity,COMPBIAS:Polar residues,DOMAIN:Integrase catalytic,DOMAIN:Peptidase A2,DOMAIN:Reverse transcriptase,REGION:Disordered,
P0CT39	retrotransposable element/transposon Tf2-type(Tf2-5)	Schizosaccharomyces pombe			GO:0006310~DNA recombination,GO:0006508~proteolysis,GO:0015074~DNA integration,	GO:0005575~cellular_component,GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0003964~RNA-directed DNA polymerase activity,GO:0004190~aspartic-type endopeptidase activity,GO:0004519~endonuclease activity,GO:0046872~metal ion binding,	IPR000477:RT_dom,IPR001584:Integrase_cat-core,IPR001969:Aspartic_peptidase_AS,IPR012337:RNaseH-like_sf,IPR021109:Peptidase_aspartic_dom_sf,IPR024648:Pept_A2E_retrotransp,IPR036397:RNaseH_sf,IPR041577:RT_RNaseH_2,IPR041588:Integrase_H2C2,IPR043128:Rev_trsase/Diguanyl_cyclase,IPR043502:DNA/RNA_pol_sf,IPR050951:Retrovirus_Pol_polyprotein,					KW-0229~DNA integration,KW-0233~DNA recombination,				KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0064~Aspartyl protease,KW-0238~DNA-binding,KW-0239~DNA-directed DNA polymerase,KW-0255~Endonuclease,KW-0378~Hydrolase,KW-0511~Multifunctional enzyme,KW-0540~Nuclease,KW-0548~Nucleotidyltransferase,KW-0645~Protease,KW-0694~RNA-binding,KW-0695~RNA-directed DNA polymerase,KW-0808~Transferase,		ACT_SITE:For protease activity,COMPBIAS:Polar residues,DOMAIN:Integrase catalytic,DOMAIN:Peptidase A2,DOMAIN:Reverse transcriptase,REGION:Disordered,
P0CT39	retrotransposable element/transposon Tf2-type(Tf2-6)	Schizosaccharomyces pombe			GO:0006310~DNA recombination,GO:0006508~proteolysis,GO:0015074~DNA integration,	GO:0005575~cellular_component,GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0003964~RNA-directed DNA polymerase activity,GO:0004190~aspartic-type endopeptidase activity,GO:0004519~endonuclease activity,GO:0046872~metal ion binding,	IPR000477:RT_dom,IPR001584:Integrase_cat-core,IPR001969:Aspartic_peptidase_AS,IPR012337:RNaseH-like_sf,IPR021109:Peptidase_aspartic_dom_sf,IPR024648:Pept_A2E_retrotransp,IPR036397:RNaseH_sf,IPR041577:RT_RNaseH_2,IPR041588:Integrase_H2C2,IPR043128:Rev_trsase/Diguanyl_cyclase,IPR043502:DNA/RNA_pol_sf,IPR050951:Retrovirus_Pol_polyprotein,					KW-0229~DNA integration,KW-0233~DNA recombination,				KW-0460~Magnesium,KW-0479~Metal-binding,	KW-0064~Aspartyl protease,KW-0238~DNA-binding,KW-0239~DNA-directed DNA polymerase,KW-0255~Endonuclease,KW-0378~Hydrolase,KW-0511~Multifunctional enzyme,KW-0540~Nuclease,KW-0548~Nucleotidyltransferase,KW-0645~Protease,KW-0694~RNA-binding,KW-0695~RNA-directed DNA polymerase,KW-0808~Transferase,		ACT_SITE:For protease activity,COMPBIAS:Polar residues,DOMAIN:Integrase catalytic,DOMAIN:Peptidase A2,DOMAIN:Reverse transcriptase,REGION:Disordered,
P79324	ribosomal protein L15(RPL15)	Sus scrofa			GO:0002181~cytoplasmic translation,GO:0006412~translation,	GO:0005634~nucleus,GO:0005840~ribosome,GO:0022625~cytosolic large ribosomal subunit,GO:0022626~cytosolic ribosome,GO:0044391~ribosomal subunit,GO:0045202~synapse,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,	IPR000439:Ribosomal_eL15,IPR012678:Ribosomal_uL23/eL15/eS24_sf,IPR020925:Ribosomal_eL15_CS,IPR024794:Rbsml_eL15_core_dom_sf,	ssc03010:Ribosome,ssc05171:Coronavirus disease - COVID-19,			SM01384:Ribosomal_L15e,		KW-0963~Cytoplasm,				KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,	KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),REGION:Disordered,
P55832	ribosomal protein S4 X-linked(RPS4X)	Equus caballus			GO:0006412~translation,	GO:0005840~ribosome,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:1990904~ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0019843~rRNA binding,	IPR000876:Ribosomal_eS4,IPR002942:S4_RNA-bd,IPR005824:KOW,IPR013843:Ribosomal_eS4_N,IPR013845:Ribosomal_eS4_central_region,IPR014722:Rib_uL2_dom2,IPR018199:Ribosomal_eS4_N_CS,IPR032277:Ribosomal_eS4_C,IPR036986:S4_RNA-bd_sf,IPR038237:Ribosomal_eS4_central_sf,IPR041982:Ribosomal_eS4_KOW,	ecb03010:Ribosome,ecb05171:Coronavirus disease - COVID-19,		PIRSF002116:Ribosomal_S4,	SM00363:S4,		KW-0472~Membrane,		KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,KW-0694~RNA-binding,KW-0699~rRNA-binding,		DOMAIN:RNA-binding S4,DOMAIN:S4 RNA-binding,TRANSMEM:Helical,
G1TFM5	ribosomal protein S5(RPS5)	Oryctolagus cuniculus			GO:0000028~ribosomal small subunit assembly,GO:0006412~translation,GO:0006450~regulation of translational fidelity,	GO:0005730~nucleolus,GO:0005840~ribosome,GO:0022626~cytosolic ribosome,GO:0022627~cytosolic small ribosomal subunit,GO:0032040~small-subunit processome,GO:0045202~synapse,	GO:0003729~mRNA binding,GO:0003735~structural constituent of ribosome,GO:0019843~rRNA binding,	IPR000235:Ribosomal_uS7,IPR005716:Ribosomal_uS7_euk/arc,IPR020606:Ribosomal_uS7_CS,IPR023798:Ribosomal_uS7_dom,IPR036823:Ribosomal_uS7_dom_sf,	ocu03010:Ribosome,ocu05171:Coronavirus disease - COVID-19,		PIRSF002122:RPS7p_RPS7a_RPS5e_RPS7o,			KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0687~Ribonucleoprotein,KW-0689~Ribosomal protein,	KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,DOMAIN:Small ribosomal subunit protein uS7,
Q920A6	serine carboxypeptidase 1(Scpep1)	Rattus norvegicus			GO:0006508~proteolysis,GO:0042573~retinoic acid metabolic process,GO:0045776~negative regulation of blood pressure,GO:0097746~blood vessel diameter maintenance,	GO:0005576~extracellular region,	GO:0004185~serine-type carboxypeptidase activity,	IPR001563:Peptidase_S10,IPR018202:Ser_caboxypep_ser_AS,IPR029058:AB_hydrolase,						KW-0964~Secreted,		KW-0732~Signal,		KW-0121~Carboxypeptidase,KW-0378~Hydrolase,KW-0645~Protease,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,REGION:Disordered,
Q6GLY8	serum/glucocorticoid regulated kinase 1 S homeolog(sgk1.S)	Xenopus laevis			GO:0006915~apoptotic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,	GO:0004674~protein serine/threonine kinase activity,GO:0004676~3-phosphoinositide-dependent protein kinase activity,GO:0004677~DNA-dependent protein kinase activity,GO:0004679~AMP-activated protein kinase activity,GO:0004694~eukaryotic translation initiation factor 2alpha kinase activity,GO:0004711~ribosomal protein S6 kinase activity,GO:0005524~ATP binding,GO:0035175~histone H3S10 kinase activity,GO:0035402~histone H3T11 kinase activity,GO:0035403~histone H3T6 kinase activity,GO:0035979~histone H2AXS139 kinase activity,GO:0044022~histone H3S28 kinase activity,GO:0044023~histone H4S1 kinase activity,GO:0044024~histone H2AS1 kinase activity,GO:0044025~histone H2BS14 kinase activity,GO:0072354~histone H3T3 kinase activity,GO:0072371~histone H2AS121 kinase activity,GO:0072518~Rho-dependent protein serine/threonine kinase activity,GO:0106310~protein serine kinase activity,GO:0140823~histone H2BS36 kinase activity,GO:0140855~histone H3S57 kinase activity,GO:0140857~histone H3T45 kinase activity,GO:1990244~histone H2AT120 kinase activity,	IPR000719:Prot_kinase_dom,IPR000961:AGC-kinase_C,IPR008271:Ser/Thr_kinase_AS,IPR011009:Kinase-like_dom_sf,IPR017441:Protein_kinase_ATP_BS,IPR017892:Pkinase_C,	xla04068:FoxO signaling pathway,xla04148:Efferocytosis,xla04150:mTOR signaling pathway,			SM00133:S_TK_X,SM00220:S_TKc,	KW-0053~Apoptosis,KW-0346~Stress response,	KW-0256~Endoplasmic reticulum,KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0418~Kinase,KW-0723~Serine/threonine-protein kinase,KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton acceptor,DOMAIN:AGC-kinase C-terminal,DOMAIN:Protein kinase,REGION:Disordered,
E6ZIJ1	sharpin and rbck1 related(shrprbck1r)	Dicentrarchus labrax			GO:0042742~defense response to bacterium,GO:0043123~positive regulation of canonical NF-kappaB signal transduction,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0097039~protein linear polyubiquitination,	GO:0071797~LUBAC complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0016740~transferase activity,GO:0043130~ubiquitin binding,GO:0046872~metal ion binding,	IPR001841:Znf_RING,IPR001876:Znf_RanBP2,IPR011993:PH-like_dom_sf,IPR013083:Znf_RING/FYVE/PHD,IPR017907:Znf_RING_CS,IPR029071:Ubiquitin-like_domsf,IPR031912:Sharpin_PH,IPR036443:Znf_RanBP2_sf,IPR044066:TRIAD_supradom,IPR047557:Rcat_RBR_HOIL1,IPR047558:BRcat_RBR_HOIL1,IPR047559:HOIL1_RBR_mRING-HC-C3HC3D,IPR051628:LUBAC_E3_Ligases,				SM00547:ZnF_RBZ,	KW-0833~Ubl conjugation pathway,			KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0808~Transferase,		COMPBIAS:Polar residues,DOMAIN:Ubiquitin-like,REGION:Disordered,REGION:TRIAD supradomain,ZN_FING:IBR-type,ZN_FING:RING-type 1,ZN_FING:RING-type 2; atypical,ZN_FING:RanBP2-type,
Q66IM1	sigma non-opioid intracellular receptor 1(sigmar1)	Xenopus tropicalis			GO:0006869~lipid transport,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005637~nuclear inner membrane,GO:0005640~nuclear outer membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0031410~cytoplasmic vesicle,		IPR006716:ERG2_sigma1_rcpt-like,					KW-0445~Lipid transport,KW-0813~Transport,	KW-0256~Endoplasmic reticulum,KW-0472~Membrane,KW-0539~Nucleus,KW-0968~Cytoplasmic vesicle,		KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0675~Receptor,		REGION:C-terminal hydrophobic region,REGION:Important for ligand-binding,SITE:Important for ligand binding,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,
Q5R7W2	solute carrier family 25 member 3(SLC25A3)	Pongo abelii			GO:1990547~mitochondrial phosphate ion transmembrane transport,	GO:0005743~mitochondrial inner membrane,	GO:0005315~phosphate transmembrane transporter activity,GO:0015293~symporter activity,GO:0015317~phosphate:proton symporter activity,GO:0044877~protein-containing complex binding,	IPR018108:Mitochondrial_sb/sol_carrier,IPR023395:Mt_carrier_dom_sf,IPR044677:SLC25A3/Pic2/Mir1-like,					KW-0769~Symport,KW-0813~Transport,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,		KW-0677~Repeat,KW-0809~Transit peptide,KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,	REGION:Disordered,REPEAT:Solcar,REPEAT:Solcar 1,REPEAT:Solcar 2,REPEAT:Solcar 3,TOPO_DOM:Mitochondrial intermembrane,TOPO_DOM:Mitochondrial matrix,TRANSIT:Mitochondrion,TRANSMEM:Helical,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,
Q5U3V7	solute carrier family 25 member 43(slc25a43)	Danio rerio			GO:0055085~transmembrane transport,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,		IPR002067:Mit_carrier,IPR018108:Mitochondrial_sb/sol_carrier,IPR023395:Mt_carrier_dom_sf,					KW-0813~Transport,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0999~Mitochondrion inner membrane,		KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,				REPEAT:Solcar 1,REPEAT:Solcar 2,REPEAT:Solcar 3,TRANSMEM:Helical; Name=1,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=6,
Q13435	splicing factor 3b subunit 2(SF3B2)	Homo sapiens			GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:1903241~U2-type prespliceosome assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005684~U2-type spliceosomal complex,GO:0005686~U2 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0016607~nuclear speck,GO:0071005~U2-type precatalytic spliceosome,GO:0071011~precatalytic spliceosome,GO:0071013~catalytic step 2 spliceosome,	GO:0003723~RNA binding,GO:0005515~protein binding,	IPR003034:SAP_dom,IPR006568:PSP_pro-rich,IPR007180:DUF382,IPR052584:U2_snRNP_Complex_Component,	hsa03040:Spliceosome,	164210~Craniofacial microsomia,		SM00513:SAP,SM00581:PSP,	KW-0507~mRNA processing,KW-0508~mRNA splicing,KW-0945~Host-virus interaction,	KW-0539~Nucleus,KW-0747~Spliceosome,	KW-0225~Disease variant,	KW-0175~Coiled coil,			KW-0007~Acetylation,KW-0488~Methylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Basic residues,COMPBIAS:Pro residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:PSP proline-rich,DOMAIN:SAP,MUTAGEN:F->A: Does not affect methylation by PRMT9; when associated with A-510.,MUTAGEN:K->A: Moderately diminished formation of omega-N monomethylarginine but greatly reduced formation of symmetrical dimethylarginine; when associated with A-507.,MUTAGEN:K->A: Moderately diminished formation of omega-N monomethylarginine but greatly reduced formation of symmetrical dimethylarginine; when associated with A-509.,MUTAGEN:K->R: Moderately diminished formation of omega-N monomethylarginine but greatly reduced formation of symmetrical dimethylarginine; when associated with R-507. Abolishes formation of omega-N monomethylarginine and formation of symmetrical dimethylarginine; when associated with K-508 and R-507.,MUTAGEN:K->R: Moderately diminished formation of omega-N monomethylarginine but greatly reduced formation of symmetrical dimethylarginine; when associated with R-509. Abolishes formation of omega-N monomethylarginine and formation of symmetrical dimethylarginine; when associated with R-508. Abolishes formation of omega-N monomethylarginine and formation of symmetrical dimethylarginine; when associated with K-508 and R-509.,MUTAGEN:R->K: Abolishes interaction with SMN1; Abolishes methylation by PRMT9. Abolishes formation of omega-N monomethylarginine and formation of symmetrical dimethylarginine; when associated with R-507. Abolishes formation of omega-N monomethylarginine and formation of symmetrical dimethylarginine; when associated with R-507. Abolishes formation of omega-N monomethylarginine and formation of symmetrical dimethylarginine; when associated with R-507 and R-509.,MUTAGEN:R->K: Does not affect methylation by PRMT9.,MUTAGEN:Y->A: Does not affect methylation by PRMT9; when associated with A-506.,REGION:Disordered,REGION:Required for interaction with PRMT9,
P50533	structural maintenance of chromosomes 2 L homeolog(smc2.L)	Xenopus laevis			GO:0030261~chromosome condensation,GO:0051276~chromosome organization,GO:0051301~cell division,	GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATP hydrolysis activity,	IPR003395:RecF/RecN/SMC_N,IPR010935:SMC_hinge,IPR024704:SMC,IPR027120:Smc2_ABC,IPR027417:P-loop_NTPase,IPR036277:SMC_hinge_sf,			PIRSF005719:SMC,	SM00968:SMC_hinge,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0226~DNA condensation,KW-0498~Mitosis,	KW-0158~Chromosome,KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0175~Coiled coil,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,			COMPBIAS:Basic and acidic residues,DOMAIN:SMC hinge,REGION:Disordered,
Q96AY4	tetratricopeptide repeat domain 28(TTC28)	Homo sapiens			GO:0007346~regulation of mitotic cell cycle,GO:0051301~cell division,	GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0030496~midbody,	GO:0019900~kinase binding,	IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,IPR024983:CHAT_dom,IPR052699:Reg/Mitotic_Spindle_Assoc,				SM00028:TPR,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,		KW-0175~Coiled coil,KW-0677~Repeat,KW-0802~TPR repeat,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:CHAT,REGION:Disordered,REPEAT:TPR,REPEAT:TPR 1,REPEAT:TPR 10,REPEAT:TPR 11,REPEAT:TPR 12,REPEAT:TPR 13,REPEAT:TPR 14,REPEAT:TPR 15,REPEAT:TPR 16,REPEAT:TPR 17,REPEAT:TPR 18,REPEAT:TPR 19,REPEAT:TPR 2,REPEAT:TPR 20,REPEAT:TPR 21,REPEAT:TPR 22,REPEAT:TPR 23,REPEAT:TPR 24,REPEAT:TPR 25,REPEAT:TPR 26,REPEAT:TPR 27,REPEAT:TPR 28,REPEAT:TPR 3,REPEAT:TPR 4,REPEAT:TPR 5,REPEAT:TPR 6,REPEAT:TPR 7,REPEAT:TPR 8,REPEAT:TPR 9,
Q80XJ3	tetratricopeptide repeat domain 28(Ttc28)	Mus musculus		Function unknown,	GO:0007346~regulation of mitotic cell cycle,GO:0051301~cell division,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0030496~midbody,GO:0072686~mitotic spindle,GO:0097431~mitotic spindle pole,GO:1990023~mitotic spindle midzone,	GO:0019900~kinase binding,	IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,IPR024983:CHAT_dom,IPR052699:Reg/Mitotic_Spindle_Assoc,				SM00028:TPR,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,		KW-0175~Coiled coil,KW-0677~Repeat,KW-0802~TPR repeat,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:CHAT,REGION:Disordered,REPEAT:TPR,REPEAT:TPR 1,REPEAT:TPR 10,REPEAT:TPR 11,REPEAT:TPR 12,REPEAT:TPR 13,REPEAT:TPR 14,REPEAT:TPR 15,REPEAT:TPR 16,REPEAT:TPR 17,REPEAT:TPR 18,REPEAT:TPR 19,REPEAT:TPR 2,REPEAT:TPR 20,REPEAT:TPR 21,REPEAT:TPR 22,REPEAT:TPR 23,REPEAT:TPR 24,REPEAT:TPR 25,REPEAT:TPR 26,REPEAT:TPR 27,REPEAT:TPR 28,REPEAT:TPR 3,REPEAT:TPR 4,REPEAT:TPR 5,REPEAT:TPR 6,REPEAT:TPR 7,REPEAT:TPR 8,REPEAT:TPR 9,
Q5ZI57	trafficking protein particle complex 3(TRAPPC3)	Gallus gallus			GO:0006888~endoplasmic reticulum to Golgi vesicle-mediated transport,GO:0006891~intra-Golgi vesicle-mediated transport,GO:0048193~Golgi vesicle transport,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0030008~TRAPP complex,GO:0033106~cis-Golgi network membrane,		IPR007194:TRAPP_component,IPR016721:Bet3,IPR024096:NO_sig/Golgi_transp_ligand-bd,			PIRSF018293:TRAPP_I_complex_Bet3,		KW-0813~Transport,KW-0931~ER-Golgi transport,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,					KW-0449~Lipoprotein,KW-0564~Palmitate,	LIPID:S-palmitoyl cysteine,
Q6P825	translocase of outer mitochondrial membrane 40 homolog(tomm40)	Xenopus tropicalis			GO:0006626~protein targeting to mitochondrion,GO:0006811~monoatomic ion transport,GO:0015031~protein transport,GO:0030150~protein import into mitochondrial matrix,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005742~mitochondrial outer membrane translocase complex,GO:0046930~pore complex,	GO:0008320~protein transmembrane transporter activity,GO:0015288~porin activity,	IPR023614:Porin_dom_sf,IPR027246:Porin_Euk/Tom40,IPR037930:Tom40,	xtr04137:Mitophagy - animal,				KW-0406~Ion transport,KW-0653~Protein transport,KW-0813~Transport,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-1000~Mitochondrion outer membrane,		KW-0812~Transmembrane,KW-1134~Transmembrane beta strand,		KW-0626~Porin,KW-0675~Receptor,		COMPBIAS:Basic and acidic residues,COMPBIAS:Pro residues,REGION:Disordered,
Q3U145	transmembrane protein 64(Tmem64)	Mus musculus			GO:0030316~osteoclast differentiation,GO:0043462~regulation of ATP-dependent activity,GO:0045600~positive regulation of fat cell differentiation,GO:0045668~negative regulation of osteoblast differentiation,GO:0045672~positive regulation of osteoclast differentiation,GO:0045780~positive regulation of bone resorption,GO:0051480~regulation of cytosolic calcium ion concentration,GO:0090090~negative regulation of canonical Wnt signaling pathway,	GO:0005783~endoplasmic reticulum,GO:0016020~membrane,	GO:0005515~protein binding,	IPR032816:VTT_dom,IPR053069:TVP38/TMEM64,	mmu04380:Osteoclast differentiation,					KW-0256~Endoplasmic reticulum,KW-0472~Membrane,		KW-0812~Transmembrane,KW-1133~Transmembrane helix,				REGION:Disordered,REGION:VTT domain,TRANSMEM:Helical,
E7FAM5	tripartite motif containing 71, E3 ubiquitin protein ligase(trim71)	Danio rerio			GO:0000082~G1/S transition of mitotic cell cycle,GO:0000209~protein polyubiquitination,GO:0007399~nervous system development,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0010172~embryonic body morphogenesis,GO:0021915~neural tube development,GO:0035278~miRNA-mediated gene silencing by inhibition of translation,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0051865~protein autoubiquitination,GO:0072089~stem cell proliferation,GO:2000177~regulation of neural precursor cell proliferation,	GO:0000932~P-body,	GO:0004842~ubiquitin-protein transferase activity,GO:0008270~zinc ion binding,GO:0035198~miRNA binding,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR000315:Znf_B-box,IPR001258:NHL_repeat,IPR001298:Filamin/ABP280_rpt,IPR001841:Znf_RING,IPR011042:6-blade_b-propeller_TolB-like,IPR013083:Znf_RING/FYVE/PHD,IPR013783:Ig-like_fold,IPR014756:Ig_E-set,IPR017868:Filamin/ABP280_repeat-like,IPR017907:Znf_RING_CS,IPR050952:TRIM-NHL_E3_ligases,				SM00184:RING,SM00336:BBOX,SM00557:IG_FLMN,	KW-0833~Ubl conjugation pathway,KW-0943~RNA-mediated gene silencing,	KW-0963~Cytoplasm,		KW-0175~Coiled coil,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0217~Developmental protein,KW-0694~RNA-binding,KW-0808~Transferase,KW-9996~Developmental protein,		DOMAIN:B box-type,DOMAIN:RING-type,REGION:Disordered,REPEAT:Filamin,REPEAT:NHL,REPEAT:NHL 1,REPEAT:NHL 2,REPEAT:NHL 3,REPEAT:NHL 4,REPEAT:NHL 5,REPEAT:NHL 6,ZN_FING:B box-type 1; atypical,ZN_FING:B box-type 2,ZN_FING:RING-type,
Q29503	ubiquitin conjugating enzyme E2 R2(UBE2R2)	Oryctolagus cuniculus			GO:0000209~protein polyubiquitination,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006513~protein monoubiquitination,GO:0070936~protein K48-linked ubiquitination,		GO:0004842~ubiquitin-protein transferase activity,GO:0005524~ATP binding,GO:0061631~ubiquitin conjugating enzyme activity,	IPR000608:UBQ-conjugat_E2,IPR016135:UBQ-conjugating_enzyme/RWD,IPR023313:UBQ-conjugating_AS,IPR050113:Ub_conjugating_enzyme,	ocu04120:Ubiquitin mediated proteolysis,			SM00212:UBCc,	KW-0833~Ubl conjugation pathway,				KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0808~Transferase,	KW-0597~Phosphoprotein,	ACT_SITE:Glycyl thioester intermediate,COMPBIAS:Acidic residues,DOMAIN:UBC core,REGION:Disordered,
Q96JH7	valosin containing protein interacting protein 1(VCPIP1)	Homo sapiens			GO:0006508~proteolysis,GO:0006974~DNA damage response,GO:0016320~endoplasmic reticulum membrane fusion,GO:0016567~protein ubiquitination,GO:0016579~protein deubiquitination,GO:0035871~protein K11-linked deubiquitination,GO:0071108~protein K48-linked deubiquitination,GO:0090168~Golgi reassembly,GO:0106300~protein-DNA covalent cross-linking repair,GO:1905634~regulation of protein localization to chromatin,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005788~endoplasmic reticulum lumen,GO:0005795~Golgi stack,	GO:0004843~cysteine-type deubiquitinase activity,GO:0005515~protein binding,	IPR003323:OTU_dom,IPR029071:Ubiquitin-like_domsf,IPR039087:VCPIP1,IPR045827:VCPIP1_N,IPR048857:OTU1_Ubl,					KW-0227~DNA damage,KW-0234~DNA repair,KW-0833~Ubl conjugation pathway,	KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0539~Nucleus,KW-0963~Cytoplasm,				KW-0378~Hydrolase,KW-0645~Protease,KW-0788~Thiol protease,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	ACT_SITE:Nucleophile,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DOMAIN:OTU,MUTAGEN:C->A: Loss of deubiquitinating activity and ability to deubiquitinate SPRTN.,MUTAGEN:S->A: Abolished phosphorylation in response to covalent DNA-protein cross-links (DPCs).,REGION:Disordered,
O60688	yippee like 1(YPEL1)	Homo sapiens				GO:0005634~nucleus,	GO:0046872~metal ion binding,	IPR004910:Yippee/Mis18/Cereblon,IPR034751:Yippee,IPR039058:Yippee_fam,						KW-0539~Nucleus,			KW-0479~Metal-binding,KW-0862~Zinc,			DOMAIN:Yippee,MOTIF:Nuclear localization signal,
